Introduction {#s1}
============

Caveolae are bulb-shaped invaginations of the plasma membrane (PM), enriched in cholesterol (Chol), sphingolipids, and the integral membrane protein caveolin1 (Cav1) ([@bib40]). Caveolae are present in most cell types, with a particularly high density in endothelial cells, adipocytes, and smooth muscle cells. Absence or malfunction of caveolae is associated with a number of conditions such as lipodystrophy, muscular dystrophy, and cardiovascular diseases ([@bib5]; [@bib42]). Although the mechanism of how caveolae dysregulation drives the phenotype of disease is not well understood, they have been proposed to serve as signaling platforms, endocytic carriers, and PM reservoirs involved in mechanoprotective processes or lipid buffering ([@bib55]; [@bib40]). In adipocytes, which are key lipid homeostasis regulators, caveolae are estimated to account for more than 50% of the cell surface area ([@bib57]). The clinical manifestation of caveolae loss in both patients ([@bib4]; [@bib24]; [@bib19]) and mouse models ([@bib44]; [@bib31]) reveals severe malfunction of adipocytes, in addition to other cell types involved in lipid turnover and storage.

Caveolae biogenesis is tightly coupled to the PM lipid composition and is thought to be driven by Chol-sensitive oligomerization of Cav1 and subsequent association with the cavin coat proteins ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}; [@bib40]). Cav1 is embedded into the lipid bilayer via its intramembrane and scaffolding domains, which interact with Chol ([@bib40]). Chol depletion from the PM causes caveolae disassembly, leading to the disassociation of cavins from Cav1, which then disseminates throughout the PM ([@bib45]; [@bib36]). Relative to the bulk PM, phosphatidylserine, glycosphingolipid (GSL), and sphingomyelin (SM) have also been proposed to be enriched in caveolae ([@bib39]; [@bib54]; [@bib20]). However, it has not been determined whether specific lipids are enriched in caveolae in living cells and, furthermore, how exactly they influence biogenesis, that is through a general physical effect on the membrane bilayer or via direct interactions with the caveolae coat proteins. Additionally, it is not known whether these lipids can diffuse freely in and out of the caveolae bulb or if they are sequestered by interactions with the caveolae coat and membrane curvature restraints.

Although caveolae are typically associated with the PM as bulb-shaped invaginations, they also exhibit dynamic behaviour including flattening ([@bib38]), short-range cycles of fission and fusion with the PM, and endocytosis ([@bib41]; [@bib3]; [@bib36]). Caveolae are stabilized at the cell surface by the ATPase Eps--15 homology domain-containing protein 2 (EHD2), which oligomerizes around the neck of caveolae in an ATP-dependent mechanistic cycle, restraining caveolae scission ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}; [@bib36]; [@bib56]). EHD2 extensively colocalizes with Cav1 and most of the membrane-associated EHD2 is found in caveolae ([@bib36]). Although not considered part of the caveolae coat, EHD2 appears to be a critical component for maintaining caveolae integrity in terms of surface attachment. All the aforementioned proposed functions of caveolae depend greatly on whether they are surface associated or released, but it is not clear how the balance between these states is controlled physiologically. Furthermore, the biological function of their atypical dynamics remains elusive ([@bib22]).

Lipids are also thought to influence caveolae dynamics, for example addition of bovine serum albumin-complexed lactosyl ceramide (LacCer) to human skin fibroblasts and elevated levels of Chol in adipocytes have been proposed to reduce the number of surface-connected caveolae and increase their mobility ([@bib49]; [@bib29]). However, despite their essential structural role in caveolae, little is known about how they influence caveolae biogenesis and dynamics. This knowledge gap can be partly attributed to limitations associated with the current methods employed to study such phenomena. Drugs such as statins, that inhibit Chol synthesis, require multi-day treatments, and, in addition to altering transcriptional regulation, may also elicit major secondary effects ([@bib6]). This results in downregulated expression of Cav1, making it difficult to decipher between the effects of Chol levels on caveolae biogenesis and caveolae dynamics. In addition, drugs such as myriocin, which inhibit sphingosine synthesis, will also affect the levels of all sphingolipid species, thus hampering direct conclusions. BSA-coupled Bodipy-LacCer has been used as a fluorescent marker of endocytosis ([@bib43]; [@bib52]; [@bib49]; [@bib53]), but this procedure involved PM loading at 4°C followed by a temperature shift to 37°C, known to heavily influence membrane fluidity and exacerbate endocytosis ([@bib26]). Previous studies have indicated that lipids might influence both caveolae numbers and their dynamics, but have been unable to address whether caveolae dynamics respond directly to alterations in PM lipid composition and if the proposed effects are dependent on concentration or species of different lipids present. In general, our understanding of the levels of quantitative changes in PM lipid composition that can be sensed and controlled is relatively sparse, not to mention the alteration in lipid composition required to influence caveolae. It is also not known if lipids could affect caveolae dynamics by changing the composition of the caveolae bulb or the surrounding membrane and whether the proposed effects on caveolae mobility are caused by direct effects on caveolae scission from the cell surface.

To address this, we aimed to rapidly and selectively manipulate cellular membrane lipid composition in a system where both the lipids and caveolae could be tracked. Here, we have applied fusogenic liposomes that allowed us to directly insert specific unlabeled or fluorescently labeled lipids into the PM of living cells and study their effect on caveolae dynamics. Our data show that a relatively small increase in glycosphingolipids and Chol results in their accumulation in caveolae, reducing the caveolae neck diameter, and driving caveolae scission from the PM. EHD2 was found to counterbalance the stability of caveolae in response to lipid composition and, in accordance with recent studies ([@bib37]; [@bib34]), we describe a key regulatory role of EHD2 in lipid homeostasis.

Results {#s2}
=======

Lipids rapidly insert into the PM of living cells via liposome-mediated membrane fusion {#s2-1}
---------------------------------------------------------------------------------------

As a tool to study the effects of altered lipid composition on caveolae dynamics, we employed fusogenic liposomes. This allowed rapid insertion of lipids into the PM of HeLa cells via membrane fusion ([Figure 1A](#fig1){ref-type="fig"}). To assess the effect of specific lipids, Bodipy-labeled analogues of sphingolipids (Cer, SM C~5~ and SM C~12~), GSLs \[ganglioside GM1 and lactosyl ceramide (LacCer)\], Chol and phosphatidyl ethanolamine (PE) ([Figure 1---figure supplement 2A](#fig1s2){ref-type="fig"}) were incorporated into liposomes \[DOPE/Dotap/Bodipy-tagged lipid (47.5/47.5/5)\] ([@bib7]). Liposomes had diameters between 160 and 300 nm ([Figure 1---figure supplement 2B](#fig1s2){ref-type="fig"}) and an average fluorescence per liposome of 600 a.u ([Figure 1---figure supplement 2C](#fig1s2){ref-type="fig"}). The Bodipy fluorophore allowed us to track and quantify lipid incorporation in the PM and study their colocalization with caveolae components. To ensure the observed effects were not significantly influenced by the fluorophore motif, the results were verified with unlabeled lipids. Liposome fusion with the PM of HeLa cells occurred immediately upon contact and the lipids were rapidly distributed throughout the basal membrane, as observed using live cell total internal reflection fluorescence (TIRF) microscopy ([Figure 1B](#fig1){ref-type="fig"} and [Figure 1---figure supplement 2D](#fig1s2){ref-type="fig"}, exemplified by LacCer). The total fluorescence attributed to the Bodipy motif increased uniformly in various regions of interest (ROIs) ([Figure 1B](#fig1){ref-type="fig"}, line graph). Lipid incorporation was similar for all cells in the population and the even distribution of lipids in the PM was observed for all lipid species (see [Figures 1B, F](#fig1){ref-type="fig"}, [2C](#fig2){ref-type="fig"} and 4A--D, [Figure 2---figure supplement 2A](#fig2s2){ref-type="fig"}, [Figure 2---videos 1](#fig2video1){ref-type="video"}, [2](#fig2video2){ref-type="video"}, [3](#fig2video3){ref-type="video"}, [4](#fig2video4){ref-type="video"}, [Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}, [Figure 4---figure supplement 2A--D](#fig4s2){ref-type="fig"}). Occasionally, bright stable spots and some enrichment of lipids in cellular protrusions were observed independent of lipid species.

![Rapid insertion of Bodipy-labeled lipids into the PM of living cells using fusogenic liposomes.\
(**A**) Fusogenic liposomes are used to insert Bodipy-labeled lipids into the PM. Their rapid distribution is followed in real time using TIRF microscopy. (**B**) Image sequence of Bodipy-LacCer distribution throughout basal membrane of HeLa cells. Total Bodipy fluorescence intensity (FI) was measured within ROIs (yellow insert) using Zeiss Zen interface. *n* = 10, three independent experiments, mean ± SEM. (**C**) Quantification of endogenous SM(d18:1/16:0) using LC-ESI-MS/MS in control cells or cells treated with SMase or myriocin for 2 hr or 24 hr, respectively. Data are shown as mean ± SD. \*\*\*, p≤0.001 vs. control. (**D**) Quantification of Bodipy- or d7-labeled lipids (black bars) and endogenous lipids (grey bars) in cells following incubation of cells with fusogenic liposomes. Analysis was performed using mass spectrometry. Data are shown as mean + SD. (**E**) Incorporation rate of Bodipy-lipids into PM of live cells. HeLa cells were treated with fusogenic liposomes (final total lipid concentration 7 nmol/ml). Total Bodipy fluorescence intensity (FI) was measured within circular ROIs (see insert) in a confocal section using spinning disk microscopy. Ten ROIs were analyzed using the Zeiss Zen system software. *n* ≥ 2, two independent experiments, mean ± SEM. Scale bars, 10 μm. (**F**) TIRF FRAP of Bodipy-lipids after incorporation into PM of HeLa cells. A circular ROI was photobleached and recovery of Bodipy FI was monitored over 5 min. Bodipy FI was normalized to background and reference. *n* ≥ 10, mean ± SEM.\
Figure 1---source data 1.Excel file containing source data pertaining to [Figure 1B--F](#fig1){ref-type="fig"}.](elife-55038-fig1){#fig1}

![GSLs and Chol decrease the surface stability of caveolae.\
(**A**) Scheme showing different dynamic behaviors of caveolae. (**B, B'**) Distribution of track mean speed among subpopulations of track duration of Cav1-mCh structures (**B**) and after EHD2 depletion (**B'**). Five datasets for each condition were analyzed from TIRF live cell movies. (**C**) Representative images from TIRF movies of Cav1-mCh HeLa cells and after 15 min incubation with liposomes containing Bodipy-lipids. Color-coded trajectories illustrate time that structures can be tracked at PM over 5 min (dotted square). Scale bars, 10 μm. See [Figure 2---videos 1](#fig2video1){ref-type="video"}, [2](#fig2video2){ref-type="video"}, [3](#fig2video3){ref-type="video"}, [4](#fig2video4){ref-type="video"}. (**D,E**) Quantification of track duration of Cav1-mCh structures from TIRF movies after incubation with liposomes containing labeled (**D**) or unlabeled lipids (**E**). Fold changes are relative to control (Cav1-mCh). (**D**) *n* ≥ 8, at least two independent experiments; (**E**) *n* ≥ 8, two independent experiments, \*\*\*, p≤0.001 vs. control. (**F**) Quantification of track mean speed of Cav1-mCh structures from TIRF movies (same cells as in (**D**)). (**G**) Quantification of track duration of Cav1-mCh structures from TIRF movies following incubation with SMase for 2 h. Fold changes are relative to control (Cav1-mCh). *n* ≥ 5. All analyses were performed using Imaris software and data are shown as mean ± SEM.\
Figure 2---source data 1.Excel file containing source data pertaining to [Figure 2B and D--G](#fig2){ref-type="fig"}.](elife-55038-fig2){#fig2}

To determine the amounts of lipids that were incorporated in the membrane through liposome fusion, we used quantitative mass spectrometry on whole cells as 90% of these lipids are located in the PM ([@bib32]). The method was verified by altering the lipid composition using myriocin (24 h treatment) or sphingomyelinase (SMase, 2 h treatment), which are known to lower the levels of sphingomyelin ([@bib16]). Analysis showed that these treatments drastically decreased SM(d18:1/16:0) levels, the major endogenous species of SM ([Figure 1C](#fig1){ref-type="fig"}). Next, we incubated cells with fusogenic liposomes containing Bodipy-labeled LacCer or SM C~12~, and analyzed the lipid composition by liquid chromatography electrospray ionization tandem mass spectrometry (LC-ESI-MS/MS). The detected levels of endogenous LacCer(d18:1/16:0) and SM(d18:1/16:0) in untreated control samples were in agreement with previously reported levels in HeLa cells ([@bib25]). In samples treated with fusogenic liposomes, the incorporated Bodipy-lipids could be specifically detected ([Figure 1---figure supplement 3A and B](#fig1s3){ref-type="fig"}). The incorporated levels of Bodipy-LacCer and Bodipy-SM C~12~ per 400 000 cells were measured to be 4.2 pmol and 2.7 pmol, respectively, (i.e., 6.3 × 10^6^ and 4.0 × 10^6^ lipids/cell) ([Figure 1D](#fig1){ref-type="fig"}). To assess the incorporation efficiency of Chol, deuterium-labeled Chol, d7-Chol, was included in fusogenic liposomes. GC-MS/MS analysis revealed that d7-Chol was incorporated to similar levels as Bodipy-labeled LacCer and SM C~12~. Given that the PM of these HeLa cells harbor around 7 × 10^9^ lipids/cell (see Materials and methods section for details), the levels of Bodipy- and d7-labeled lipids detected by mass spectrometry led to a 0.02--0.09% increase in specific labeled lipids and a 0.4--1.6% of total lipids.

To determine the rate of incorporation of the different Bodipy-labeled lipid species, we used spinning disk microscopy in a central confocal plane of the cell ([Figure 1E](#fig1){ref-type="fig"}). Quantitative analysis of lipid incorporation into the PM over time revealed similar levels for most lipids ranging from 1900 to 4800 arbitrary units at 10 min ([Figure 1E](#fig1){ref-type="fig"}). The variation in incorporation rates between the different lipids may result from differences in the fusogenicity of the liposomes or differences in the PM-turnover of each particular lipid. To monitor the lateral diffusion of the Bodipy-lipids within the PM, cells were incubated with fusogenic liposomes, and fluorescence recovery after photobleaching (FRAP) in a defined ROI was monitored. All lipids showed similar smooth and rapid recovery after bleaching ([Figure 1F](#fig1){ref-type="fig"}). Although, as previously observed ([@bib23]), the diffusion rate and mobile fraction of specific lipids displayed slight variations when measured by FRAP in living cells.

To conclude, the use of fusogenic liposomes enabled rapid incorporation of approximately 4 × 10^6^ specific lipids into the PM per living cell over 10 min. To put this into context, we estimated that each cell contains around 300 caveolae, based on our staining and tracking data ([Figure 1---figure supplement 4C](#fig1s4){ref-type="fig"}), comprising around 0.1% of the surface area. Caveolae are approximately 60 nm in diameter, and each lipid occupies 0.62 Å. Therefore *ca.* 10 × 10^6^ lipids are contained within the caveolae, of which 50% is Chol. This means that the amount of specific incorporated lipids in our system is about half of the total amount of lipids contained within caveolae. The immediate addition of extra lipids to the PM did not result in a detectable effect on the cell volume ([Figure 1---figure supplement 2E](#fig1s2){ref-type="fig"}).

Single particle tracking reveals caveolae dynamics in living cells {#s2-2}
------------------------------------------------------------------

We next aimed to elucidate whether lipids are involved in controlling the balance between stable and dynamic caveolae at the PM, and if effects could be attributed to individual lipid species. To visualize caveolae, we generated a stable mammalian Flp-In T-Rex HeLa cell line expressing Cav1-mCherry, hereafter named Cav1-mCh HeLa cells. Expression of Cav1-mCherry was induced by doxycycline (Dox) at endogenous Cav1 levels, resulting in similar caveolae numbers to those without induction ([Figure 1---figure supplement 4A--C](#fig1s4){ref-type="fig"}). Using TIRF microscopy and single-particle tracking, we determined the time each Cav1-mCh positive punctuate structure spent at the PM (track duration) and the speed of an object (track mean speed) in, or close to, the PM (see Materials and method section for detailed tracking parameters and [Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}). Given the previously reported surface dynamics of caveolae ([@bib41]; [@bib3]; [@bib35]), we postulated that stable caveolae will have a long duration and low speed, limited by their lateral diffusion in the PM ([Figure 2A](#fig2){ref-type="fig"}, 'Stable'). Caveolae that scission off or re-fuse with the PM during the recording period will give rise to shorter mean duration and increased mean speed. Caveolae that remain close to the surface and undergo rounds of scission and fusion, will result in an overall increase in tracks ([Figure 2A](#fig2){ref-type="fig"}). Caveolae disassembly will give rise to shorter tracks but no increase in mean speed and importantly a major loss of tracks. We did indeed observe a clear correlation between the track duration and track mean speed where, in general, short tracks exhibited higher speeds, whereas long tracks displayed lower speeds ([Figure 2B](#fig2){ref-type="fig"} and [Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}). Although the numbers of caveolae in each cell were similar at the beginning and end of the recording, we found that the number of tracks far exceeded the caveolae numbers ([Figure 2---figure supplement 2B](#fig2s2){ref-type="fig"}). This was expected as surface adjacent caveolae would give rise to several tracks. However, a drop in the fluorescent signal just below the set threshold value, would also contribute to a divided track, resulting in an overestimation of short tracks versus long tracks. Therefore, we did not consider the average duration and speed as absolute, but rather used them to compare between experimental runs with differing conditions. To verify that the tracking was sensitive to differences in caveolae dynamics, we depleted cells of EHD2, which has been shown to stabilize caveolae to the cell surface ([@bib36]; [@bib56]). Particle tracking analysis showed that the pool of tracks with high speed increased, while the pool with low speed decreased ([Figure 2B'](#fig2){ref-type="fig"} and [Figure 2---figure supplement 1B](#fig2s1){ref-type="fig"}). When the average track duration was considered, this translated into a 0.65 fold decrease compared to control cells ([Figure 3E](#fig3){ref-type="fig"}), proving that the particle tracking was indeed sensitive enough to register caveolae scission induced by removal of EHD2.

![Chol and GSLs induce surface release of caveolae via an EHD2-dependent mechanism.\
(**A**) Representative images of maximum projected confocal z-stacks of Cav1-mCh HeLa cells. Untreated cells or cells treated with LacCer-Bodipy liposomes for 1 h, fixed and immunostained for endogenous EHD2. High-magnification images (dotted square) show localization of EHD2 to Cav1-mCh (see scatterplot for quantification). *n* ≥ 60, two independent experiments, mean ± SEM. \*\*\*, p≤0.001 vs. control. (**B**) Experimental protocols analogous to (**A**), with exception of endogenous cavin1 immunostaining. *n* ≥ 60, mean ± SEM. (**C**) Confocal FRAP of Cav1-mCh HeLa cells treated with either EHD2 siRNA or Bodipy-LacCer liposomes. A ROI was photobleached and recovery of mCherry FI monitored over 5 min. mCherry FI was normalized to background and reference. *n* ≥ 10, mean ± SEM. (**D**) Representative time-lapse series showing control Cav1-mCh HeLa cells and cells treated with either EHD2 siRNA or Bodipy-LacCer liposomes. The photobleached area is outlined with white circles. mCherry FI is intensity‐coded using LUT. (**E**) Effects of lipids on track duration of Cav1-mCh structures were analyzed following siRNA-mediated depletion of EHD2. *n* ≥ 8, two independent experiments, mean ± SEM. (**F**) Quantification of track duration of untreated Cav1-mCh HeLa cells or cells transiently expressing EHD2-BFP with or without incubation with liposomes. Changes in track duration are relative to EHD2-BFP control (indicated by dotted line). *n* ≥ 8, two independent experiments, mean + SEM. \*\*\*, p≤0.001 vs. control cells. (**G**) Representative live cell confocal image of EHD2-647 microinjected into Cav1-mCh HeLa cells. (**H**) Quantification of track duration of Cav1-mCh cells treated with Bodipy-LacCer and following microinjection of EHD2-647. *n* = 8, mean + SEM. All scale bars, 10 μm.\
Figure 3---source data 1.Excel file containing source data pertaining to [Figure 3A--C,E,F and H](#fig3){ref-type="fig"}.](elife-55038-fig3){#fig3}

Caveolae surface stability is influenced by distinct lipid composition {#s2-3}
----------------------------------------------------------------------

Next, we screened the influence of different lipid species on caveolae mobility at the PM using tracking. To do this, fusogenic liposomes loaded with relevant lipids were added to Cav1-mCh HeLa cells, and TIRF movies were recorded immediately ([Figure 2C](#fig2){ref-type="fig"}). PE was used in control liposomes as it is abundant in the PM. Following incorporation of PE, caveolae dynamics remained unchanged, showing that the fusion of liposomes did not obstruct caveolae dynamics ([Figure 2D](#fig2){ref-type="fig"} and [Figure 2---figure supplement 2A](#fig2s2){ref-type="fig"}). In comparison to controls, Bodipy-labeled GSLs (GM1 and LacCer) and Chol significantly reduced the lifetime of caveolae at the cell surface as indicated by decreased track duration and increased mean speed ([Figure 2C,D,F](#fig2){ref-type="fig"}, [Figure 2---figure supplement 2A](#fig2s2){ref-type="fig"}, [Figure 2---videos 1](#fig2video1){ref-type="video"}, [2](#fig2video2){ref-type="video"}, [3](#fig2video3){ref-type="video"}). For example, LacCer treatment increased the number of fast moving and short-lived caveolae versus slow moving and long-lived species, which was comparable to the EHD2 depletion ([Figure 2B'](#fig2){ref-type="fig"}, [Figure 2---figure supplement 1B--D](#fig2s1){ref-type="fig"} and [Figure 2---figure supplement 2C](#fig2s2){ref-type="fig"}).

A direct comparison between LacCer and Cer revealed that Cer did not enhance caveolae dynamics in a similar fashion ([Figure 2D and F](#fig2){ref-type="fig"} and [Figure 2---figure supplement 2A](#fig2s2){ref-type="fig"}). No difference was observed in the number of caveolae present in the PM before and after the addition of liposomes ([Figure 2---figure supplement 2C](#fig2s2){ref-type="fig"}), showing that caveolae were not disassembled and indicating that most of the scissioned caveolae remained surface adjacent. To verify that the effect was not an artifact of the Bodipy label, we treated cells with liposomes containing either unlabeled LacCer \[(LacCer(d18:1/16:0)\], unlabeled Chol or unlabeled SM \[(SM(d18:1/16:0)\] and quantified the track duration. This showed that the unlabeled lipids had the same effect on the caveolae dynamics as the corresponding Bodipy-labeled analogues ([Figure 2E](#fig2){ref-type="fig"}). Interestingly, when cells were treated with unlabeled SM or Bodipy-SM C~12~, most of the caveolae were stable at the PM. This was characterized by a dramatic increase in track duration, and a reduction of the track mean speed ([Figure 2D--F](#fig2){ref-type="fig"}). However, incorporation of SM C~5~ did not significantly alter caveolae dynamics, suggesting that the fatty acid chain length was important for this effect. Even at three times the amount (3x SM C~5~) to control for incorporation rate, no effect was observed ([Figure 2D](#fig2){ref-type="fig"} and [Figure 2---figure supplement 2D](#fig2s2){ref-type="fig"}). To further investigate the role of SM, we analyzed caveolae duration following SMase treatment, and found that this resulted in a decreased track duration, in agreement with a surface-stabilizing role for this lipid ([Figure 2G](#fig2){ref-type="fig"}).

Chol and GSLs induce scission of caveolae via mechanisms that are counteracted by EHD2 {#s2-4}
--------------------------------------------------------------------------------------

EHD2 normally localizes with the majority of surface associated caveolae ([@bib36]). We aimed to address whether the increased caveolae dynamics induced by either Chol or GSLs were caused by their PM release, as characterized by loss of the stabilizing protein EHD2. Therefore, we treated Cav1-mCh HeLa cells with the fusogenic liposomes and visualized endogenous EHD2 using indirect immunofluorescent labeling ([Figure 3A](#fig3){ref-type="fig"}). These experiments revealed that incorporation of GM1, LacCer, or Chol into the PM led to a significantly lower amount of EHD2 that colocalized with Cav1 ([Figure 3A](#fig3){ref-type="fig"}, scatter plot). These data suggest that the caveolae release induced by increased PM levels of LacCer and Chol is results from loss of EHD2-mediated stabilization. Conversely, Cer and SM C~12~, as well as its short chain analogue SM C~5~, did not appear to have any significant effect on the association of EHD2 with Cav1 ([Figure 3A](#fig3){ref-type="fig"}, scatter plot). Furthermore, following lipid treatment, the majority of caveolae remained associated with cavin1 ([Figure 3B](#fig3){ref-type="fig"}). To verify that caveolae at the cell surface were not disassembled via detachment of cavin1, we compared the colocalization of Cav1-mCh with cavin1-GFP before and after lipid treatment using TIRF microscopy ([Figure 3---figure supplement 1A--B](#fig3s1){ref-type="fig"}). These data showed that there was no significant change in the number of cavin-decorated caveolae following incorporation of any of the specific lipids, revealing that no disruption of the caveolae coat, and subsequent release of cavin1 occurred.

As increased scission of caveolae from the cell surface results in more mobile intracellular caveolar vesicles ([@bib56]), we performed fluorescence recovery after photobleaching (FRAP) experiments to investigate the recovery rate of caveolae. Addition of LacCer resulted in more mobile caveolae inside the cells in comparison with control cells ([Figure 3C--D](#fig3){ref-type="fig"}). The recovery rate after LacCer addition was similar to the rate in EHD2-depleted cells (see [Figure 3---figure supplement 2A](#fig3s2){ref-type="fig"} for protein levels). This further supported the hypothesis that lipid incorporation drives caveolae scission. When LacCer or Chol were added to EHD2-depleted cells we found that the caveolae track duration was not further reduced in comparison with EHD2-depleted cells ([Figure 3E](#fig3){ref-type="fig"} and [Figure 3---figure supplement 2B](#fig3s2){ref-type="fig"} for control siRNA). These results supported our hypothesis that the lipid-induced effect on caveolae dynamics resulted from loss of surface stability mediated by EHD2, and implied that EHD2 controls the stability of caveolae in response to lipid composition.

To test whether increased levels of EHD2 could restore caveolae stability after lipid treatment, we transiently expressed blue fluorescent protein (BFP)-tagged EHD2 in Cav1-mCh HeLa cells. Analysis of TIRF live cell movies showed that EHD2-BFP positive caveolae were highly stable compared to untreated cells ([Figure 3F](#fig3){ref-type="fig"}). In the presence of EHD2-BFP, the destabilizing effect seen for GM1, LacCer, and Chol was abolished, as demonstrated by negligible changes in track duration compared to control conditions ([Figure 3F](#fig3){ref-type="fig"}). This suggested that excess levels of EHD2 were capable of restricting the effect of excess Chol and GSLs. In addition, tracking of caveolae in cells stably expressing Cav1-mCh and EHD2-BFP showed that most caveolae were positive for EHD-BFP (96%) and that this population was more stable than the population lacking EHD2-BFP (4%) ([Figure 3---figure supplement 3A--C](#fig3s3){ref-type="fig"}). Surprisingly, SM C~12~ had an additive effect and led to predominantly stable caveolae ([Figure 3F](#fig3){ref-type="fig"}), suggesting that here the stabilizing effect of SM is increased in the presence of excess levels of EHD2. Furthermore, EHD2 could partly restrict the increase in caveolae dynamics observed in response to SMase treatment and decreased SM levels in the PM. These data suggested that SM and EHD2 both stabilize caveolae, but perhaps via alternate mechanistic pathways.

To test whether EHD2-mediated suppression of the lipid effect relied on multiple rounds of EHD2 assembly and disassembly at caveolae, we overexpressed a BFP-tagged ATP-cycle mutant, EHD2-I157Q. The increased ATP hydrolysis rate of this mutant leads to stable association of EHD2-I157Q to caveolae and a slower exchange rate ([Figure 3---figure supplement 3D](#fig3s3){ref-type="fig"}; [@bib9]; [@bib56]; [@bib21]). We observed that, when co-expressed in Cav1-mCh cells, both EHD2-I157Q and EHD2 stabilized caveolae at the PM to similar extents, independent of treatment with either LacCer or Chol ([Figure 3---figure supplement 3E](#fig3s3){ref-type="fig"}). This verified that stable assembly, but not disassembly of EHD2, is necessary to stabilize caveolae.

To clarify whether, in order to have a stabilizing role, EHD2 had to be caveolae-associated prior to lipid addition, fluorescently labeled, purified EHD2 (EHD2-647) was microinjected into Cav1-mCh HeLa cells ([Figure 3G](#fig3){ref-type="fig"}). Within 20 min, EHD2-647 colocalized with Cav1, confirming that the microinjected protein was indeed recruited to caveolae ([Figure 3---figure supplement 4A--B](#fig3s4){ref-type="fig"}). Next, we tested whether an acute injection of EHD2-647 could rescue the effect on caveolae dynamics caused by LacCer. Strikingly, we found that exogenously added EHD2 stabilized the caveolae to the same extent as the overexpressed EHD2, demonstrating that increased levels of EHD2 can acutely reverse the increased mobility of caveolae induced by lipids ([Figure 3H](#fig3){ref-type="fig"}).

Chol and SM are sequestered within caveolae {#s2-5}
-------------------------------------------

As SM C~12~ increased the surface stability of caveolae, while GSLs and Chol promoted scission, we investigated whether there was a differential accumulation of these lipids within caveolae at the PM. We treated Cav1-mCh HeLa cells with fusogenic liposomes and followed the distribution of Bodipy-labeled lipids using live cell TIRF microscopy. After 15 min, LacCer, Chol , and SM C~12~ lipids were found to colocalize with Cav1-mCh positive structures ([Figure 4---figure supplement 2A--D](#fig4s2){ref-type="fig"} and [Figure 4---videos 1](#fig4video1){ref-type="video"} and [2](#fig4video2){ref-type="video"}). Data analysis was hindered by high caveolae mobility following addition of LacCer and Chol, and the extent of colocalization could not be quantified. To circumvent this, we overexpressed EHD2-BFP to stabilize caveolae at the PM. Interestingly, nearly 80% of caveolae positive for EHD2 were also positive for LacCer, Chol, and SM C~12~ ([Figure 4A--C](#fig4){ref-type="fig"}, [Figure 4---figure supplement 1A--B](#fig4s1){ref-type="fig"} and [Figure 4---videos 3](#fig4video3){ref-type="video"} and [4](#fig4video4){ref-type="video"}). In comparison, Cer, which had no effect on caveolae dynamics, did not localize to caveolae, even in the presence of EHD2-BFP ([Figure 4D](#fig4){ref-type="fig"}, [Figure 4---figure supplement 1A](#fig4s1){ref-type="fig"} and [Figure 4---figure supplement 2D](#fig4s2){ref-type="fig"}).

![LacCer, Chol, and SM accumulate in caveolae and Chol is sequestered within these domains.\
(**A--D**) Cav1-mCh HeLa cells transiently expressing EHD2-BFP were incubated with Bodipy-lipids. White lines indicate location of kymograph. TIRF movies were recorded at 3 s intervals for 5 min. Scale bars, 10 μm; kymograph scale bars, 5 μm. See [Figure 4---videos 3](#fig4video3){ref-type="video"} and [4](#fig4video4){ref-type="video"}. (**E**) Cav1-mCh HeLa cells transiently expressing EHD2-BFP were incubated with Bodipy-LacCer for 10 min. Following photobleaching (yellow ROI), recovery of Bodipy signal within caveolae (red ROI) and bulk PM (cyan ROI) was monitored over time. White arrows highlight surface connected caveolae with accumulated Bodipy-LacCer. Scale bar, 10 μm. (**F**) Recovery curves of Bodipy intensities within caveolae ROI (red) and bulk PM ROI (cyan). Bodipy FI was normalized to background and reference.\
Figure 4---source data 1.Excel file containing source data pertaining to [Figure 4F](#fig4){ref-type="fig"}.](elife-55038-fig4){#fig4}

To investigate lipid exchange between the stable caveolae and the surrounding PM, we performed FRAP experiments. The Bodipy-LacCer signal reappeared rapidly at precisely the bleached spot positive for Cav1-mCh, with a close to quantitative fluorescence recovery ([Figure 4E--F](#fig4){ref-type="fig"}). This indicated that the lipid diffused freely throughout the PM and, following photobleaching, re-accumulated quickly within caveolae. In comparison, Bodipy-Chol recovered much slower with 60% of the initial signal being restored after 5 min acquisition time ([Figure 4F](#fig4){ref-type="fig"} and [Figure 4---figure supplement 3A](#fig4s3){ref-type="fig"}). This showed that there is a large immobile pool of Chol in caveolae that is sequestered from the rest of the PM. The signal from Bodipy-SM C~12~ was almost exclusively detected in caveolae hampering recovery measurements outside of this domain ([Figure 4---figure supplement 3B--C](#fig4s3){ref-type="fig"}). However, the recovery rate of the SM C~12~ within caveolae was very low, showing that SM C~12~ is also sequestered in caveolae in the presence of EHD2. Our data suggest that LacCer, Chol, and SM C~12~ are highly enriched in caveolae and, while the lateral diffusion of LacCer in and out of caveolae is high, Chol and SM C~12~ are restrained to this invagination.

Chol accumulation reduces the caveolae diameter in 3T3-L1 adipocytes {#s2-6}
--------------------------------------------------------------------

To elucidate whether lipid accumulation affected the overall morphology of surface connected caveolae in Cav1-mCh HeLa cells, we analyzed their ultrastructure in cells overexpressing EHD2. As the number of caveolae in the PM of these cells is relatively low, we used correlative light electron microscopy (CLEM) to specifically identify fluorescently tagged caveolae by combining light microscopy with the higher resolution images of transmission electron microscopy (TEM). Fluorescence light microscopy images of Cav1-mCh HeLa cells were superimposed with correlative electron micrographs to find the closest match of fluorescence signal to structure using the nuclear stain as a guide ([Figure 5---figure supplement 1A](#fig5s1){ref-type="fig"}). The surface connected caveolae in cells treated with LacCer, Chol, and SM C~12~, displayed a similar flask-shaped morphology to that seen in control cells, verifying that lipid addition did not majorly distort caveolae morphology ([Figure 5A](#fig5){ref-type="fig"} and [Figure 5---figure supplement 1B](#fig5s1){ref-type="fig"}).

![Chol accumulation reduces the caveolae diameter in 3T3 adipocytes.\
(**A**) Representative overlays of light microscopy images with corresponding electron micrographs showing localization of caveolae (Cav1-mCh in red) and nuclei (DAPI in cyan) for untreated Cav1-mCh HeLa cells (control) or cells treated with Bodipy-labeled Chol or LacCer. Dotted boxes show regions of higher magnification in corresponding panels below. N, nucleus; PM, plasma membrane. White arrows denote surface connected caveolae and black arrows indicate surface adjacent caveolae. Scale bars, 1 μm; inset scale bars, 100 nm. (**B, C**) Electron micrographs of control 3T3-L1 adipocytes (**B**) and 3T3-L1 adipocytes treated with Bodipy-Chol (**C**). Top and bottom panels show two representative images per sample: one with clear surface connected necks and one without. Cells were chemically fixed, embedded in resin, and processed for electron microscopy. Scale bars, 100 nm. (**D, D'**) Scatter plots showing the quantification of neck diameter (**D**) and bulb width (**D'**) of surface connected caveolae in 3T3-L1 adipocytes. Bulb width and neck diameter are highlighted in (**B**), upper panel. *n* ≥ 30, mean ± SEM. (**E, E'**) Scatter plots showing the quantification of surface area (**E**) and bulb width (**E'**) of surface adjacent caveolae in 3T3-L1 adipocytes. *n* ≥ 120, mean ± SEM. \*\*\*, p≤0.001.\
Figure 5---source data 1.Excel file containing source data pertaining to [Figure 5D and E](#fig5){ref-type="fig"}.](elife-55038-fig5){#fig5}

To quantitatively assess differences in morphology related to caveolae scission in a more physiologically relevant system, we used adipocytes as they are a main source of cholesterol storage and efflux ([@bib27]), but are devoid of LacCer ([@bib39]). We differentiated 3T3-L1 cells to adipocytes, which results in upregulation of Cav1 and EHD2 ([Figure 5---figure supplement 2A](#fig5s2){ref-type="fig"}; [@bib37]), and formation of a large number of caveolae ([@bib57]) that could be clearly distinguished from clathrin-coated pits ([Figure 5---figure supplement 2B](#fig5s2){ref-type="fig"}). Lipid incorporation quantification verified that fusogenic liposomes could be used to insert specific lipids into the PM of these cells ([Figure 5---figure supplement 2C](#fig5s2){ref-type="fig"}). Using TEM, we analyzed the dimensions of caveolae before and after Chol addition ([Figure 5B--E](#fig5){ref-type="fig"}). We found that the neck diameter of surface associated caveolae were significantly decreased and more homogeneous following Chol incorporation in comparison to control cells ([Figure 5D](#fig5){ref-type="fig"}). Furthermore, the bulb width was also significantly smaller resulting in more drop-shaped caveolae ([Figure 5D](#fig5){ref-type="fig"}´). Quantitative analysis of the caveolae population where a clear surface connected neck could not be detected allowed measurement of the surface area of caveolae. Comparison to control cells showed that area, as well as bulb width, decreased following Chol addition ([Figure 5E--E](#fig5){ref-type="fig"}´). Furthermore, Chol incorporation resulted in a more homogeneous caveolae population in terms of size and dimensions. These data suggested that an acute increase in Chol levels in the PM of 3T3-adipocytes induced alterations in the caveolae coat architecture, resulting in reduced neck diameter and a smaller more uniform bulb diameter.

GSLs are internalized to the endosomal system independently of Cav1, while Chol is predominantly trafficked to lipid droplets {#s2-7}
-----------------------------------------------------------------------------------------------------------------------------

Next, we aimed to address whether caveolae scission significantly contributed to internalization and trafficking of lipids in our system as previously proposed ([@bib43]; [@bib29]; [@bib51]). We used fusogenic liposomes to investigate whether Bodipy-labeled LacCer or Chol were internalized and trafficked through the endosomal pathway following incorporation into the PM. To mark early endosomes (EE), Rab5-BFP was transiently expressed in Cav1-mCh HeLa cells. Cells were incubated with fusogenic liposomes for either 15 min or 3 h, followed by fixation and EE localization was quantified. We observed localization of LacCer to the EE but not to the Golgi, contrasting previous studies using BSA-Bodipy-LacCer ([@bib43]). After 15 min, more than half of the EE were positive for LacCer (55%) compared to only 6% for Chol ([Figure 6A--B](#fig6){ref-type="fig"}). After 3 h, the number of LacCer-positive EE remained constant, whereas the EE positive for Chol had increased to 18% ([Figure 6B](#fig6){ref-type="fig"}). The amount of caveolae that colocalized with EE was very low, both before and after treatment with lipids ([Figure 6C](#fig6){ref-type="fig"}). To test if caveolae were involved in lipid trafficking to the EE, the experiments were repeated in cells depleted of Cav1 ([Figure 6D--F](#fig6){ref-type="fig"}). After 15 min incubation time, 55% and 10% of EE were positive for LacCer and Chol, respectively ([Figure 6D--E](#fig6){ref-type="fig"}). This suggested that while caveolae did not seem to influence the efficiency of LacCer or Chol trafficking to endosomes, loss of Cav1 resulted in an increased amount of Chol accumulating in this compartment. Our data indicate that caveolae serve as buffers or sensors of GSL and Chol concentrations rather than endocytic vesicles.

![GSLs are internalized to the endosomal system independent of Cav1, while Chol is predominantly trafficked to lipid droplets.\
(**A**) Cav1-mCh HeLa cells expressing Rab5-BFP were incubated with Bodipy-labeled LacCer or Chol for 15 min. Individual channels are shown for selected areas (dotted box). (**B**) Colocalization of lipids with Rab5-positive structures after indicated time-points. (**C**) Quantification of Cav1-mCh localization to Rab5-BFP positive structures before (control) and after lipid addition. Statistical analysis: ns - non significant. (**D**) Cav1 siRNA-treated Cav1-mCh HeLa cells expressing Rab5-BFP after incubation with Bodipy-labeled LacCer or Chol for 15 min. High-magnification images of selected areas (dotted box) for each channel are shown. (**E**) Quantification of EE positive for lipids in cells treated with siRNA control or against Cav1. Cells were incubated with Bodipy-lipids for 15 min. (**F**) Representative immunoblots of Cav1-mCh HeLa cells treated with control siRNA or siRNA against Cav1. Clathrin HC served as loading control. (**G**) Cav1-mCh HeLa cells were incubated with Bodipy-lipids for 15 min, fixed and LDs were stained using LipidTOX-DR. (**H**) Colocalization of lipids to LDs. (**I**) Colocalization of lipids with LDs in cells depleted of Cav1 after 15 min. (**B, C, E, H, I**) *n* = 10, mean ± SEM. All scale bars, 5 μm.\
Figure 6---source data 1.Excel file containing source data pertaining to [Figure 6B,C,E,H and I](#fig6){ref-type="fig"}.](elife-55038-fig6){#fig6}

During our experiments, we noticed that a large fraction of Chol localized to compartments distinct from the endosomal system. To determine whether Chol localized to lipid droplets (LD) as previously proposed ([@bib29]; [@bib51]), we incubated HeLa cells with fusogenic liposomes and visualized LD using LipidTOX-DR. On average, 85% of LDs were positive for Chol after both 15 min and 3 h ([Figure 6G--H](#fig6){ref-type="fig"}), and similar levels of Chol-positive LD were detected in cells lacking Cav1 ([Figure 6I](#fig6){ref-type="fig"}). While Chol extensively localized to LD, we did not observe LacCer associated with LD ([Figure 6G--I](#fig6){ref-type="fig"}). These data are consistent with the hypothesis that excess Chol in the PM is trafficked directly to LD in a process that does not require caveolae per se, and that the levels of Chol taking an alternative route to EE increase in the absence of caveolae.

Discussion {#s3}
==========

While PM turnover is typically regulated in a tightly controlled manner, marginal changes in its composition are associated with severe diseases such as cancer, diabetes, and Alzheimer's disease ([@bib18]). It has been proposed that caveolae play a major role in preserving lipid homeostasis via sensing and buffering PM properties ([@bib42]; [@bib40]). However, studies detailing how lipid composition influences cellular phenotypes have been hindered by a lack of methods to selectively manipulate the PM lipid composition; especially with regard to introducing specific lipids. To address this, we applied an approach for studying these systems in living cells that employs DOPE/DOTAP-based liposomes capable of mediating highly effective fusion processes with cell membranes to deliver their lipid cargoes. Such liposomes have previously been used as nanocarriers to deliver intracellular proteins ([@bib28]). Our methodology successfully delivered specific lipids into the PM bilayer of living cells with high efficiency. These rapid fusion events have allowed us to report the first studies observing caveolae response to acute changes in PM lipid composition, as well as lipid exchange itself in the caveolae bulb. Furthermore, the use of labelled lipids allowed us to measure their incorporation relative to endogenous levels. Our results demonstrate the power of this approach for studying caveolae dynamics and we foresee that our methodology will also be a useful tool outside of this framework.

Our work shows that the surface association of caveolae is highly sensitive to changes in the PM lipid composition. An acute increase in the levels of Chol and GSLs, which were found to specifically accumulate in caveolae, dramatically increased caveolae mobility. These caveolae traveled at higher speeds, their PM duration was shorter and they also displayed reduced levels of EHD2, a protein indicative of PM-associated caveolae. Therefore, we conclude that accumulation of Chol and GSLs in caveolae triggers surface release of caveolae. In agreement with this, EM analysis revealed that the caveolae neck diameter was reduced in cells with elevated Chol levels. Our findings are consistent with previous reports suggesting that BSA-LacCer and Chol decrease the number of caveolae associated to the PM and enhance their mobility ([@bib49]; [@bib29]). Based on the present study, increased caveolae mobility is a direct result of accumulation of these lipids in caveolae. As our methodology allowed us to determine the levels of specifically incorporated lipids, we found that rapid, yet relatively small increases in specific lipids can affect caveolae dynamics. Because caveolae immediately responded to these changes in bilayer composition, we propose that they serve as PM sensors, not only for membrane tension, but also for lipid composition.

Previous studies have suggested that a threshold concentration of Chol is required to maintain caveolae integrity and proposed that assembly and disassembly is in a dynamic equilibrium dependent on Chol levels ([@bib17]). This is also in line with our experiments showing that excess Chol drives caveolae assembly towards scission and that Chol was indeed found to accumulate in caveolae when these structures were restrained to the surface by EHD2 overexpression. Furthermore, our methodology enabled, for the first time, measurement of lipid lateral flow in and out of the caveolae bulb using FRAP. Comparing the FRAP recovery of Bodipy-LacCer and Bodipy-Chol, which were both enriched in caveolae, showed that while photobleached Bodipy-LacCer was almost fully exchanged via lateral diffusion after 2 min, photobleached Bodipy-Chol was only exchanged by 50%. This showed that Chol was sequestered in caveolae, potentially through its interaction to Cav1 ([@bib40]). In contrast, Bodipy-Cer, which lacks the disaccharide structural motif of LacCer, did not accumulate in caveolae and had no effect on their dynamics, which is in agreement with earlier reports ([@bib49]). Precisely how the lactosyl group mediates the caveolae-enrichment of LacCer and how this in turn drives caveolae scission is not clear.

Interestingly, we found that SM and Bodipy-SM C~12~, but not Bodipy-SM C~5~, dramatically increased caveolae stability, in terms of both speed and duration. This suggests that the chain length is important and might influence their interactions with for example Chol. SM has been shown to sequester a pool of Chol in the PM, which, together with an accessible and inaccessible pool, aid in the sensing of the Chol levels in the PM ([@bib8]). The elevated levels of SM may alter the levels of SM-sequestered Chol, thereby affecting caveolae stability. In agreement with this, we found that a dramatic reduction of SM using SMase increased caveolae dynamics. SM was highly enriched in caveolae, especially in cells with elevated EHD2 levels. This shows that this lipid has a direct role in caveolae, but the mechanism by which SM stabilizes caveolae requires more detailed investigation.

Although an area of extensive research, a consensus on the exact mechanism of caveolae scission has not yet been reached. Our observations suggest a model, where the accumulation of lipids in caveolae reduces the neck diameter, leading to scission. We speculate that this could be caused by increased access of scission-mediating molecules like dynamin to the neck, or that that these lipids promote assembly of Cav1 and cavins, which drive curvature towards scission. The lipid-driven assembly of Cav1 may be an intrinsically unstable system, eventually resulting in scission if no restraining forces are applied. This indicates that scission is tightly coupled to, and a continuum of, caveolae biogenesis. In line with this, expression of caveolin in bacterial systems induced the formation of internal caveolae-like vesicles containing caveolin so-called heterologous caveolae ([@bib58]). The scission step could also involve lipid phase separation. A similar mechanism has previously been proposed but not experimentally validated ([@bib30]), and our new data show that a locally increased concentration of GSLs and Chol in caveolae may induce phase separation and therefore facilitate budding and scission of caveolae. Consistent with this, model membrane studies have shown that sterol-induced phase separation can promote membrane scission ([@bib2]; [@bib46]). Of interest, in other systems GSLs and Chol have been suggested to play a crucial role in membrane nanodomain budding to generate intracellular transport carriers ([@bib48]).

EHD2 has been shown to confine caveolae to the cell surface ([@bib36]; [@bib56]). In the current study, we acutely altered the lipid composition to induce caveolae scission and analyzed the immediate role of EHD2. We found that removal of EHD2, while at the same time changing the lipid composition, did not have an additive effect on caveolae dynamics. However, excess levels of EHD2 from overexpression or direct microinjection, could suppress the effect of the altered lipid composition. This suggests that an increased assembly rate of EHD2 at the caveolae neck is necessary and sufficient to drive the equilibrium towards stable surface association of caveolae. We conclude that oligomers of EHD2 might provide a restraining force that prevents reduction of the neck diameter and thereby inhibits phase separation or assembly of scission-mediating proteins. Similarly, EHD2 would prevent flattening of caveolae and thus, act to stabilize the typical bulb-shape of caveolae. Our data also indicate that EHD2 could limit lipid diffusion of Chol and SM over the caveolae neck thereby influencing caveolae stability. Therefore, EHD2 would act as a key regulator of caveolae dynamics in response to changes in both PM lipid composition and membrane tension.

Caveolae have been proposed to play an integral role in intracellular lipid trafficking ([@bib43]; [@bib29]; [@bib51]). This prompted us to examine the cellular fate of our labelled lipids. We found that while Bodipy-LacCer was internalized via the endosomal system, Chol predominately localized to LD. Importantly, and in contrast to previous data ([@bib51]), we found that loss of caveolae did not majorly influence the trafficking of these lipids in HeLa cells. Based on this, we propose that caveolae should not be considered as vehicles for internalization of lipids, but rather that lipid composition influences caveolae biogenesis and dynamics. Together with the caveolae coat components, it is feasible that sequestered lipids may control formation and define the size and curvature of these PM invaginations. This, together with our data showing that Chol is enriched and sequestered in caveolae, implies that caveolae could serve as reservoirs of Chol in the PM, thereby buffering the surface levels of this lipid.

Together, our findings indicate that the dynamic behavior of caveolae is highly sensitive to changes in PM lipid composition. We demonstrate that, following incorporation into the lipid bilayer, GSLs and Chol accumulate in caveolae, which promotes scission of these membrane invaginations from the cell surface. The current study redefines the fundamental understanding of how caveolae dynamics are governed by biologically relevant lipids and will be of future relevance linking caveolae malfunction with lipid disorders.

Materials and methods {#s4}
=====================

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\                   Designation                                                                               Source or reference               Identifiers                                                    Additional\
  (species) or resource                                                                                                                                                                                                      information
  ------------------------------- ----------------------------------------------------------------------------------------- --------------------------------- -------------------------------------------------------------- ------------------------------------------------------------------------------
  Antibody                        anti-PTRF\                                                                                Abcam                             Cat \# ab48824\                                                IF(1:100)
                                  (Rabbit polyclonal)                                                                                                         RRID:[AB_88224](https://scicrunch.org/resolver/AB_88224)       

  Antibody                        anti-EHD2\                                                                                ([@bib36])                        RRID:[AB_2833022](https://scicrunch.org/resolver/AB_2833022)   IF (1:500), WB(1:2000)
                                  (Rabbit polyclonal)                                                                                                                                                                        

  Antibody                        anti-clathrin heavy chain (clone 23; mouse monoclonal)                                    BD Transduction Laboratories      Cat \# 610499\                                                 WB (1:1000)
                                                                                                                                                              RRID:[AB_397865](https://scicrunch.org/resolver/AB_397865)     

  Antibody                        anti-caveolin-1\                                                                          Abcam                             Cat \# ab2910\                                                 IF (1:500)\
                                  (Rabbit, polyclonal)                                                                                                        RRID:[AB_303405](https://scicrunch.org/resolver/AB_303405)     WB (1:10 000)

  Antibody                        anti-rabbit IgG secondary antibody coupled to Alexa Fluor 647 (Goat polyclonal)           Thermo Fisher Scientific          Cat \# A21246\                                                 IF (1:300)
                                                                                                                                                              RRID:[AB_2535814](https://scicrunch.org/resolver/AB_2535814)   

  Chemical compound, drug         1,2-dioleoyl-sn\                                                                          Avanti Polar Lipids               Cat \# 850725                                                  
                                  -glycero-3-phosphoethanolamine (DOPE)                                                                                                                                                      

  Chemical compound, drug         1,2-dioleoyl-3-trimethylammonium-propane (chloride salt) (DOTAP)                          Avanti Polar Lipids               Cat \# 890890                                                  

  Chemical compound, drug         Bodipy FL C5- Ganglioside GM1                                                             Thermo Fisher Scientific          Cat \# B13950                                                  

  Chemical compound, drug         Bodipy FL C5-LacCer                                                                       This study\                                                                                      
                                                                                                                            ([@bib14])                                                                                       

  Chemical compound, drug         Bodipy FL C5-ceramide                                                                     Thermo Fisher Scientific          Cat \# D3521                                                   

  Chemical compound, drug         Bodipy-Cholesterol                                                                        Avanti Polar Lipids               Cat \# 810255                                                  

  Chemical compound, drug         Bodipy FL C12-spinghomyelin                                                               Thermo Fisher Scientific          Cat \# D7711                                                   

  Chemical compound, drug         Bodipy FL C5-spinghomyelin                                                                Thermo Fisher Scientific          Cat \# D3522                                                   

  Chemical compound, drug         Bodipy FL succinimidyl ester (EverFluor FL)                                               Setareh Biotech                   Cat \# 7150                                                    

  Chemical compound, drug         D-lactosyl-ß1--1\'-D-erythro-sphingosine                                                  Avanti Polar Lipids               Cat \# 860542                                                  

  Chemical compound, drug         D-lactosyl-ß−1,1\' N-palmitoyl-D-erythro-sphingosine                                      Avanti Polar Lipids               Cat \# 860576                                                  

  Chemical compound, drug         Cholesterol                                                                               Sigma Aldrich                     Cat \# C3045                                                   

  Chemical compound, drug         N-Palmitoyl-D-sphingomyelin                                                               Sigma Aldrich                     Cat\# 91553                                                    

  Chemical compound, drug         Sphingomyelinase (SMase) (from *Bacillus cereus*)                                         Sigma Aldrich                     Cat\# S7651                                                    

  Chemical compound, drug         Myriocin (from *Mycelia sterilia*)                                                        Sigma Aldrich                     Cat\# M1177                                                    

  Chemical\                       Paraformaldehyde 16%                                                                      Electron Microscopy Sciences      Cat \# 15710                                                   
  compound, drug                                                                                                                                                                                                             

  Chemical compound, drug         Paraformaldehyde                                                                          Thermo Fisher Scientific          Cat \# PA0095                                                  

  Chemical compound, drug         Glutaraldehyde 25%                                                                        Taab Laboratory Equipment Ltd     Cat \# G011/2                                                  

  Chemical compound, drug         3-isobutyl-1-methylxanthine (IBMX)                                                        Sigma Aldrich                     Cat \# I5879                                                   

  Chemical\                       Dexamethasone (Dex)                                                                       Sigma Aldrich                     Cat \# D4902                                                   
  compound, drug                                                                                                                                                                                                             

  Chemical compound, drug         Insulin                                                                                   Sigma Aldrich                     Cat \# I0516                                                   

  Chemical compound, drug         rosiglitazone                                                                             Cayman Chemicals                  71740                                                          

  Chemical compound, drug         Lipofectamine2000                                                                         Thermo Fisher Scientific          Cat \# 11668019                                                

  Chemical compound, drug         *N*,*N*-Diisopropylethylamine                                                             Sigma Aldrich                     Cat \# D125806                                                 

  Chemical compound, drug         *N*,*N*-Dimethylformamide, anhydrous                                                      Sigma Aldrich                     Cat \# 227056                                                  

  Chemical compound, drug         Chloroform                                                                                VWR                               Cat \# VWRC22711.324                                           

  Chemical compound, drug         Methanol                                                                                  Thermo Fisher Scientific          Cat \# 15394528                                                

  Chemical\                       Doxycycline hyclate                                                                       Sigma Aldrich                     Cat \# D9891                                                   
  compound, drug                                                                                                                                                                                                             

  Chemical compound, drug         Hygromycin B                                                                              Thermo Fisher Scientific          Cat \# 10687010                                                

  Chemical compound, drug         Blasticidin S HCl                                                                         Thermo Fisher Scientific          Cat \# R210-01                                                 

  Cell line (*Homo-sapiens*)      HeLa\                                                                                     ATCC                              Cat \# CRM-CCL-2\                                              
                                  (cervix)                                                                                                                    RRID:[CVCL_0030](https://scicrunch.org/resolver/CVCL_0030)     

  Cell line (*M. musculus*)       3T3-L1 (Pre-adipocytes)                                                                   ATCC                              Cat \# ATC-CL-173\                                             
                                                                                                                                                              RRID:[CVCL_0123](https://scicrunch.org/resolver/CVCL_0123)     

  Cell line (*Homo-sapiens*)      HeLa FlpIn T-Rex Caveolin1-mCherry                                                        This study                                                                                       

  Cell line (*Homo-sapiens*)      HeLa FlpIn T-Rex EHD2pTagBFP-P2A-Caveolin1-mCherry                                        This study                                                                                       

  Transfected construct (human)   siRNA to EHD2\                                                                            Thermo Fisher Scientific          Cat\#1299001 Assay ID HSS121265                                
                                  (Stealth)                                                                                                                                                                                  

  Transfected construct (human)   Scrambled 353 siRNA\                                                                      Thermo Fisher Scientific          Cat\# 12935300                                                 
                                  (Stealth)                                                                                                                                                                                  

  Transfected construct (human)   siRNA to Caveolin1\                                                                       Thermo Fisher Scientific          Cat \#1299001 Assay ID HSS141467                               
                                  (Stealth)                                                                                                                                                                                  

  Recombinant DNA reagent         Rab5-TagBFP                                                                               ([@bib13])                                                                                       under control of P~CMV\ IE~promotor in pTagBFP-N vector

  Recombinant DNA reagent         EHD2-TagBFP                                                                               This study                                                                                       under control of P~CMV\ IE~promotor in pTagBFP-N vector

  Recombinant DNA reagent         EHD2 I157Q-TagBFP                                                                         This study                                                                                       under control of P~CMV\ IE~promotor in pTagBFP-N vector

  Recombinant DNA reagent         EHD2-mCherry                                                                              ([@bib21])                                                                                       under control of P~CMV\ IE~promotor in pmCherry-N1 vector

  Recombinant DNA reagent         mCherry-EHD2                                                                              This study                                                                                       under control of P~CMV\ IE~promotor in pmCherry-C1 vector

  Recombinant DNA reagent         EHD2 I157Q-mCherry                                                                        This study                                                                                       under control of P~CMV\ IE~promotor in pmCherry-N1 vector

  Recombinant DNA reagent         mCherry-EHD2 I157Q                                                                        This study                                                                                       under control of P~CMV\ IE~promotor in pmCherry-C1 vector

  Recombinant DNA reagent         pCDNA/FRT/TO caveolin1-mCherry                                                            This study                                                                                       under control of P~CMV\ IE~ promotor

  Recombinant DNA reagent         pCDNA/FRT/TO EHD2-pTagBFP-P2A-caveolin1-mCherry                                           This study                                                                                       under control of P~CMV\ IE~ promotor

  Software, algorithm             ImageJ/Fiji                                                                               Fiji\                             RRID:[SCR_002285](https://scicrunch.org/resolver/SCR_002285)   <http://fiji.sc/>
                                                                                                                            ([@bib47])                                                                                       

  Software, algorithm             Imaris x64 9.1.2                                                                          Bitplane                          RRID:[SCR_007370](https://scicrunch.org/resolver/SCR_007370)   <http://www.bitplane.com/imaris>

  Software, algorithm             Prism 5.0                                                                                 GraphPad                          RRID:[SCR_002798](https://scicrunch.org/resolver/SCR_002798)   <https://www.graphpad.com/scientific-software/prism/>

  Software, algorithm             Photoshop CS6                                                                             Adobe                             RRID:[SCR_014199](https://scicrunch.org/resolver/SCR_014199)   <https://www.adobe.com/se/products/photoshop.html>

  Software, algorithm             Illustrator CS6                                                                           Adobe                             RRID:[SCR_010279](https://scicrunch.org/resolver/SCR_010279)   <https://www.adobe.com/se/products/photoshop.html>

  Software, algorithm             Maps 3.3                                                                                  FEI                                                                                              <https://www.fei.com/software/maps/>

  Software, algorithm             Zen interface 2.3                                                                         Zeiss                             RRID:[SCR_013672](https://scicrunch.org/resolver/SCR_013672)   <https://www.zeiss.com/microscopy/int/products/microscope-software/zen.html>

  Software, algorithm             Nis Elements 4.3                                                                          Nikon                             RRID:[SCR_014329](https://scicrunch.org/resolver/SCR_014329)   <https://www.nikoninstruments.com/en_EU/Products/Software>

  Other                           Aluminum backed silica gel plates (median pore size 60 Å, fluorescent indicator 254 nm)   Fisher Scientific                 Cat \# 10517771                                                

  Other                           Chromatography grade silica gel (0.035--0.070 mm, 60 Å)                                   Acros Organic                     Cat \# 240360050                                               

  Other                           Formvar TEM grids                                                                         Taab Laboratory Equipment Ltd     Cat \# F005                                                    

  Other                           CS-25R17 coverlips (TIRF)                                                                 Warner Instruments                Cat \# 64--0735                                                

  Other                           CS-25R15 coverlips                                                                        Warner Instruments                Cat \# 64--0715                                                

  Other                           Precision cover glasses thickness No. 1.5H                                                Paul Marienfeld GmbH and Co. KG   Cat \# 0117520                                                 

  Other                           PD-10 columns                                                                             GE Healthcare                     Cat \# 17-0851-0                                               

  Other                           MatTek dishes (35 mm dish, high tolerance 1.5)                                            MatTek Corporation                Cat \# P35G-0.170--14 C                                        

  Other                           HCS LipidTOX Deep Red Neutral Lipid Stain                                                 Thermo Fisher Scientific          Cat \# H34477                                                  

  Other                           Dulbecco\'s Modified Eagle Medium (DMEM)                                                  Thermo Fisher Scientific          Cat \# 41966052                                                

  Other                           Opti-MEM I Reduced Serum Medium                                                           Thermo Fisher Scientific          Cat \# 31985070                                                

  Other                           Dulbecco\'s Modified Eagle Medium (DMEM), no phenol red                                   Thermo Fisher Scientific          Cat \# 21063029                                                

  Other                           Sodium pyruvate                                                                           Thermo Fisher Scientific          Cat \# 11360039                                                

  Other                           Dako Fluorescent Medium                                                                   Dako                              Cat \# S3023                                                   

  Other                           Alexa Fluor 647 C2 Maleimide                                                              Thermo Fisher Scientific          Cat \# A20347                                                  

  Other                           DAPI (4\',6-Diamidino-2-Phenylindole, Dilactate)                                          Thermo Fisher Scientific          Cat \# D3571                                                   

  Other                           Fetal bovine serum                                                                        Thermo Fisher Scientific          Cat \# 16000044                                                
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Reagents {#s4-1}
--------

1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE), 1,2-dioleoyl-3-trimethylammonium-propane (chloride salt) (DOTAP), TopFluor-cholesterol (Bodipy-Chol), TopFluor- phosphatidylethanolamine (Bodipy-PE), D-lactosyl-ß−1,1\' N-palmitoyl-D-erythro-sphingosine \[LacCer(d18:1/16:0)\] and Lyso-Lactosylceramide (Lyso-LacCer) were purchased from Avanti Polar Lipids Inc (Alabaster, AL, US). Bodipy FL C5-ganglioside GM1 (Bodipy-GM1), Bodipy FL C5-ceramide (Bodipy-Cer), Bodipy FL C~12~-spinghomyelin (Bodipy-SM C~12~), Bodipy FL C~5~-spinghomyelin (Bodipy-SM C~5~) were obtained from Thermo Fisher Scientific (Waltham, MA, US). BODIPY Fl-C5 NHS ester (4,4-Difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacene-3-pentanoic acid, succinimidyl ester) was purchased from Setareh Biotech, LLC (Eugene, OR, US). Sphingomyelin (SM d18:1/16:0), cholesterol (Chol), d7-cholesterol, *N*,*N*-diisopropylethylamine, sphingomyelinase (SMase) from *Bacillus cereus*, myriocin from *Mycelia sterilia*, anhydrous dimethylforamide (DMF), chloroform (CHCl~3~), and methanol (MeOH) were purchased from Sigma-Aldrich (St. Louis, MO, US). LC-MS grade formic acid was purchased from VWR Chemicals (Radnor, PA, US). LC-MS grade 2-propanol and acetonitrile were from Merck Millipore (Billerica, MA, US). Milli-Q water (Merck Millipore) was used. All reagents and chemicals were used without further purification.

Bodipy-LacCer synthesis {#s4-2}
-----------------------

Thin layer chromatography was performed on aluminum backed silica gel plates (median pore size 60 Å, fluorescent indicator 254 nm, Fisher Scientific, Hampton, NH, US), visualized by exposure to UV light (365 nm), and stained with acidic ethanolic vanillin solution. Flash chromatography was performed using chromatography grade silica gel (0.035--0.070 mm, 60 Å, Thermo Fisher Scientific). NMR spectra were recorded on a Bruker AVANCE (600 MHz) spectrometer. ^1^H Chemical shifts are reported in δ values relative to tetramethylsilane and referenced to the residual solvent peak (CD~3~OD: δ~H~ = 3.31 ppm, δ~C~ = 49.00 ppm). Coupling constants are reported in Hz.

Lyso-LacCer (5 mg, 8 μM) was dissolved in DMF (200 μl) and *N*,*N*-diisopropylethylamine (2.1 μl, 12 μM, 1.5 eq.) was added. BODIPY Fl-C5 NHS ester (66 μl of a stock solution of 5 mg/100 μl DMF, 8 μM, 1.0 eq.) was added and the reaction was shielded from light and stirred for 14 h. The reaction mixture was concentrated and purified by column chromatography (CHCl~3~, MeOH, H~2~O, 70:15:2 -- 65:25:2) to afford the product Bodipy-LacCer (6.5 mg, 88%, [Figure 1---figure supplement 2---source data 1](#fig1s2sdata1){ref-type="supplementary-material"}) as a red film ([@bib14]).

Retention factor: R~f~ = 0.46 (CHCl~3~, MeOH, H~2~O, 65:25:2).

NMR data: ^1^H-NMR (CD~3~OD, 600 MHz) δ 7.41 (1H, s), 7.03 (1H, d, *J* = 4.1 Hz), 6.36 (1H, d, *J* = 4.0 Hz), 6.18 (1H, s), 5.67 (1H, dt, *J* = 15.3, 6.8 Hz), 5.44 (1H, dd, *J* = 15.3, 7.7 Hz), 4.34 (1H, d, *J* = 7.7 Hz), 4.29 (1H, d, *J* = 7.8 Hz), 4.17 (1H, dd, *J* = 10.1, 4.7 Hz), 4.07 (1H, t, *J* = 7.9 Hz), 3.99 (1H, ddd, *J* = 8.2, 4.6, 3.3 Hz), 3.89 (1H, dd, *J* = 12.1, 2.6 Hz), 3.84 (1H, dd, *J* = 12.2, 4.3 Hz), 3.81 (1H, d, *J* = 3.1 Hz), 3.78 (1H, dd, *J* = 11.4, 7.5 Hz), 3.70 (1H, dd, *J* = 11.5, 4.6 Hz), 3.61--3.59 (1H, m), 3.62--3.51 (3H, m), 3.52--3.49 (1H, m), 3.47 (1H, dd, *J* = 9.7, 3.3 Hz), 3.39 (1H, ddd, *J* = 9.3, 4.0, 2.7 Hz), 3.28 (1H, t, *J* = 8.5 Hz), 2.94 (2H, t, *J* = 7.3 Hz), 2.50 (3H, s), 2.28 (3H, s), 2.25 (2H, t, *J* = 7.0 Hz), 2.00--1.93 (2H, m), 1.79--1.66 (4H, m), 1.37--1.20 (31H, m, (11-CH~2~)), 0.89 (3H, t, *J* = 7.0 Hz).

^13^C-NMR (CD~3~OD, 151 MHz) δ 175.7, 160.9, 160.2, 145.0, 136.1, 135.2, 134.9, 131.2, 130.0, 125.6, 120.9, 117.9, 105.1, 104.5, 80.6, 77.1, 76.5, 76.3, 74.8, 74.8, 73.0, 72.5, 70.3, 69.9, 62.5, 61.8, 54.8, 37.1, 33.4, 33.1, 30.8, 30.8, 30.8, 30.8, 30.8, 30.7, 30.5, 30.4, 30.3, 29.5, 29.4, 27.0, 23.7, 14.9, 14.5, 11.2.

Cell lines and primary cultures {#s4-3}
-------------------------------

HeLa cells (ATCC-CRM-CCL-2, RRID:[CVCL_0030](https://scicrunch.org/resolver/CVCL_0030)) were cultured in Dulbecco\'s Modified Eagle Medium (DMEM, Thermo Fisher Scientific) supplemented with 10% (v/v) fetal bovine serum (FBS, Thermo Fisher Scientific) at 37°C, 5% CO~2~. For generation of HeLa Flp-In T-REx Caveolin1-mCherry cells, the pcDNA/FRT/TO/Caveolin1-mCherry construct was generated by exchanging the EGFP-tag in the pcDNA/FRT/TO/Caveolin1-EGFP ([@bib35]) for a mCherry tag by restriction cloning using enzymes AgeI and NotI (Thermo Fisher Scientific). The HeLa Flp-In T-REx EHD2-BFP-P2A-Caveolin1-mCherry construct was generated by linearizing pcDNA/FRT/TO/Caveolin1-mCh with the restriction enzyme HindIII (Thermo Fisher Scientific). The DNA encoding EHD2-BFP and the P2A peptide was inserted by Gibson assembly using NEBuilder HiFi DNA assembly master mix (New England BioLabs, Ipswich, MA, USA). The Flp-In TRex HeLa cell lines were maintained in DMEM supplemented with 10% (v/v) FBS, 100 μg/ml hygromycin B (Thermo Fisher Scientific), and 5 μg/ml blasticidin S HCl (Thermo Fisher Scientific) for plasmid selection at 37°C, 5% CO~2~. Expression at endogenous levels was induced by incubation with 0.5 ng/ml (Cav1-mCh) and 1.0 ng/ml (EHD2-BFP-P2A-Cav1mCh) doxycycline hyclate (Dox, Sigma-Aldrich) for 16--24 h. All cell lines tested negative for mycoplasma.

3T3-L1 fibroblasts (ATC-CL-173, RRID:[CVCL_0123](https://scicrunch.org/resolver/CVCL_0123)) were maintained in DMEM supplemented with 10% (v/v) FBS and penicillin-streptomycin (10000 U/ml, 1:100, Thermo Fisher Scientific) at 37°C, 5% CO~2~, and differentiated to adipocytes as previously described ([@bib59]). Briefly, cells were either seeded directly into a six-well plate or on glass coverslips in a six-well plate at 6 × 10^5^ cells/well (day −3 of differentiation). The cells reached confluency the following day and the medium was changed (day −2). After 48 h (day 0) the medium was exchanged for differentiation medium I \[supplemented DMEM containing 0.5 mM 3-isobutyl-1-methylxanthine (IBMX, Sigma Aldrich), 0.25 μM dexamethasone (Dex, Sigma Aldrich), 1 μg/ml insulin (Sigma Aldrich) and 2 μM rosiglitazone (Cayman Chemical, Ann Arbor, MI, USA)\]. Following incubation for 48 h, the medium was changed to differentiation medium II (supplemented DMEM containing 1 μg/ml insulin) (day 2). Experiments were performed on day 4 of differentiation.

Fusogenic liposomes {#s4-4}
-------------------

Liposomes were prepared from a lipid mixture of DOPE, DOTAP, and either Bodipy-tagged lipid or unlabeled lipid at a ratio of 47.5:47.5:5. Lipid blends were in MeOH:CHCl~3~ (1:3, v/v). Following the generation of a thin film using a stream of nitrogen gas, the vesicles were formed by addition of 20 mM HEPES (VWR, Stockholm, SE, pH 7.5, final lipid concentration 2.8 μmol/ml) and incubated for 1.5 h at room temperature. Glass beads were added to facilitate rehydration. The liposome dispersion was sonicated for 30 min (Transsonic T 310, Elma, Singen, DE). The hydrodynamic diameters (*z*-average) of the liposomes were measured using dynamic light scattering with a Malvern Zetasizer Nano-S (Malvern Instruments, Worcestershire, UK). Samples were diluted 1:100 in 20 mM HEPES (pH 7.5) and measured using a UV-transparent disposable cuvettes (Sarstedt, Nümbrecht, DE). The measurements were performed at 20°C. The Nano DTS Software 5.0 was used for acquisition and analysis of the data.

Lipid quantification by LC-ESI-MS/MS {#s4-5}
------------------------------------

One day prior to experiment, cells were seeded in a six-well plate. Cells were left untreated or treated with 11.7 nmol/ml of the different fusogenic liposomes for 10 min at 37°C, 5% CO~2~. The cells were washed three times with PBS and harvested in 500 μl MeOH by scraping. Counting revealed that approximately 4 × 10^5^ cells were obtained per sample. For myriocin (2.5 μM) and SMase (0.01 U) treatment, cells were incubated for 24 h or 2 h, respectively. Extraction was performed using a mixer mill set to a frequency 30 Hz for 2 min, with one tungsten carbide bead added to each tube. Thereafter the samples were centrifuged at 4°C, 14000 RPM, for 10 min. A volume of 260 μl of the supernatant was transferred to micro vials and evaporated under N~2~ (g) to dryness. The dried extracts were stored at −80°C until analysis. Calibration curves of Bodipy-labeled standards (Bodipy-SM C~12~ and Bodipy-LacCer) as well as standards for endogenous LacCer and SM \[LacCer(d18:1/16:0) and SM(d18:1/16:0)\] were prepared prior to analysis. Stock solutions of each compound were prepared at a concentration of 500 ng/μl and stored at −20°C. A five-point calibration curve (0.025--0.4 ngl/μl) was prepared by serial dilutions \[Bodipy-SM C~12~R^2^ = 0.9909; LacCer(d18:1/16:0) R^2^ = 0.9945; Bodipy-LacCer R^2^ = 0.9983; LacCer(d18:1/14:0) R^2^ = 0.8742\], except for endogenous SM(d18:1/16:0) where 0.025--10.0 ng/μl was used (R^2^ = 0.9991). Samples and calibration curves were analyzed using a 1290 Infinitely system from Agilent Technologies (Waldbronn, Germany), consisting of a G4220A binary pump, G1316C thermostated column compartment, and G4226A autosampler with G1330B autosampler thermostat coupled to an Agilent 6490 triple quadrupole mass spectrometer equipped with a jet stream electrospray ion source operating in positive ion mode. Separation was achieved injecting 2 μl of each sample (resuspended in 20 μl of MeOH) onto a CSH C~18~2.1 × 50 mm, 1.7 μm column (Waters, Milford, MA, USA) held at 60°C in a column oven. The gradient eluents used were 60:40 acetonitrile:H~2~O (A) and 89:10.5:0.4 isopropanol:acetonitrile:water (B), both with 10 mM ammonium formate and 0.1% formic acid, with a flow rate of 500 μl/min. The initial conditions consisted of 15% B, and the following gradient was used with linear increments: 0--1.2 min (15--30% B), 1.2--1.5 (30--55% B), 1.5--4.0 (55% B), 4.0--4.8 (55--100% B), 4.8--6.8 (100% B), 7.1--8.0 (15% B). The MS parameters were optimized for each compound ([Table 1](#table1){ref-type="table"}). The fragmentor voltage was set at 380 V, the cell accelerator voltage at 5 V and the collision energies from 20 to 30 V, nitrogen was used as collision gas.

###### Retention times (RT), MRM-transition stages monitored (precursor ion and product ions) and collision energies of analyzed compounds.

  Compounds            MRM transition   RT (min)   Collision energy (V)   
  -------------------- ---------------- ---------- ---------------------- ----
  Bodipy-LacCer        926.5            562.4      1.48                   30
  LacCer(d18:1/16:0)   862.6            520.5      2.84                   20
  LacCer(d18:1/14:0)   834.6            264.3      2.8                    40
  SM(d18:1/16:0)       703.6            184.1      2.9                    30
  Bodipy-SM C~12~      865.6            184.1      2.12                   30

Jet-stream gas temperature was at 150°C with a gas flow of 16 l/min. The sheath gas temperature was kept at 350°C with a gas flow of 11 l/min. The nebulizer pressure was set to 35 psi and the capillary voltage was set at 4 kV. The QqQ was run in Dynamic MRM Mode using a retention time delta of 0.8 min and 500 ms cycle scans. The data were quantified using MassHunter Quantitative Analysis (Agilent Technologies, Atlanta, GA, USA).

Cholesterol quantification by GC-MS {#s4-6}
-----------------------------------

One day prior to experiment cells were seeded in a six-well plate. Cells were left untreated or treated with 11.7 nmol/ml fusogenic liposomes for 10 min at 37°C, 5% CO~2~. The cells were washed three times with PBS and harvested in 250 μl MeOH by scraping, and two wells were pooled to generate approximately 8 × 10^5^ cells per 500 μl sample into Eppendorf tubes. Extraction was performed using a mixer mill set to a frequency 30 Hz for 2 min, with one tungsten carbide bead added to each tube. Obtained extracts were centrifuged at 4°C, 14000 RPM for 10 min. A volume of 300 μl of the collected supernatants was transferred to individual micro vials and the extracts were dried under N~2~ (g) to dryness. Separate calibration curves were prepared for endogenous and d7-Chol. A six-point calibration curve spanning from 0 to 10 ng/μl was prepared for d7-Chol (R^2^ = 0.9909). For endogenous Chol a six-point calibration curve spanning from 0 to 500 ng/μl was prepared (R^2^ = 0.9969). Methyl stearate at a final concentration of 5 ng/μl was used as internal standard in both calibration curves. Derivatization was performed according to a previously published method ([@bib15]). In detail, 10 μl of methoxyamine (15 μg/μl in pyridine) was added to the dry sample that was shaken vigorously for 10 min before it was left to react at room temperature. After 16 h, 10 μl of MSTFA was added, the sample was shaken and left to react for 1 h at room temperature. A volume of 10 μl of methyl stearate (15 ng/μl in heptane) was added before analysis. For d7-cholesterol quantification, 1 μl of the derivatized sample was injected by an Agilent 7693 autosampler, in splitless mode into an Agilent 7890A gas chromatograph equipped with a multimode inlet (MMI) and 10 m x 0.18 mm fused silica capillary column with a chemically bonded 0.18 μm DB 5 MS UI stationary phase (J and W Scientific). The injector temperature was 250°C. The carrier gas flow rate through the column was 1 ml min^−1^, the column temperature was held at 60°C for 1 min, then increased by 60°C min^-1^ to 300°C and held there for 2 min. The column effluent is introduced into the electron impact (EI) ion source of an Agilent 7000C QQQ mass spectrometer. The thermal AUX 2 (transfer line) and the ion source temperatures were 250°C and 230°C, respectively. Ions were generated by a 70 eV electron beam at an emission current of 35 μA and analyzed in dMRM-mode. The solvent delay was set to 3 min. For a list of MRM transitions see [Table 2](#table2){ref-type="table"}. For endogenous Chol analysis, the samples were reanalyzed in split mode (10:1) together with the Chol calibration curve. The data were quantified using MassHunter Quantitative Analysis (Agilent Technologies, Atlanta, GA, USA).

###### MRM transitions for labeled and endogenous Chol.

  Compound          Comment   Precursor ion   MS1 resolution   Product ion   MS2 resolution   RT    RT delta min (total)
  ----------------- --------- --------------- ---------------- ------------- ---------------- ----- ----------------------
  Methyl stearate   IS-std    298             Unit             101.1         Unit             5.6   2
  Chol              Quant     329             Unit             95            Unit             7.8   2
  Chol              Qual      368             Unit             213           Unit             7.8   2
  d7-Chol           Quant     336             Unit             95            Unit             7.8   2
  d7- Chol          Qual      375             Unit             213           Unit             7.8   2

Calculations of the number of PM lipids {#s4-7}
---------------------------------------

The average PM area of fibroblast is around 3000 μm^2^ ([@bib50]), of which 23% is estimated to be occupied by proteins ([@bib12]), which translates into the average PM of a cell containing approximately 7 × 10^9^ lipids ([@bib1]). Our data are in agreement with these reported values, with our measured values for SM(d18:1/16:0) being 40% of total SM species ([@bib25]), and 21 mol% of PM lipids translating to 9.6 × 10^9^ lipids in the PM.

Assessment of lipid incorporation into the PM with live cell spinning disk microscopy {#s4-8}
-------------------------------------------------------------------------------------

One day prior to the experiment, non-induced Cav1-mCh HeLa cells or 3T3-L1 adipocytes were seeded on glass coverslips (CS-25R17 or CS-25R15, Warner Instruments, Hamden, CT, US) in a six-well plate at 3 × 10^5^ cells/well (37°C, 5% CO~2~). Live cell experiments were conducted in phenol red-free DMEM (live cell medium, Thermo Fisher Scientific) supplemented with 10% FBS and 1 mM sodium pyruvate (Thermo Fisher Scientific) at 37°C in 5% CO~2~. To follow the distribution of Bodipy throughout the PM, a POC mini two chamber (PeCon, Erbach, DE) was used that allowed addition of the fusogenic liposomes during data acquisition. Liposomes were added at a concentration of 7 nmol/ml and movies of confocal stacks were recorded every 30 s over a period of 5 min using a 63X lens and Zeiss Spinning Disk Confocal controlled by ZEN interface (RRID:[SCR_013672](https://scicrunch.org/resolver/SCR_013672)) with an Axio Observer.Z1 inverted microscope, equipped with a CSU-X1A 5000 Spinning Disk Unit and an EMCCD camera iXon Ultra from ANDOR. For TIRF movies the same system was used but employing a 100X lens and an Axio Observer.Z1 inverted microscope equipped with an EMCCD camera iXonUltra from ANDOR. The increase in fluorescence intensity (FI) of the Bodipy signal was measured within circular ROIs, which were either evenly distributed over the PM seen in the confocal section or over the basal PM in the case of TIRF. The total FI was determined by calculating integrated density (area x FI), which was then background corrected. Ten ROIs per cell were analyzed using Zeiss Zen interface (*n* = 3, two independent experiments). Based on lipids occupying 65 Å^2^, which translates to 3.1 × 10^6^ lipid molecules/μm^2^ ([@bib11]), and that mean liposome diameter was 225 nm, corresponding to an area of 0.19 μm^2^, we calculated that each liposome contained 0.6 × 10^6^ lipids, of which 5% were Bodipy-labeled. To estimate the cell volume, the cell surface was segmented with the surface feature within the Imaris x64 9.1.2 RRID:[SCR_007370](https://scicrunch.org/resolver/SCR_007370) (Bitplane, Zurich, CH) using the mCherry fluorescence.

Constructs, transfections, and cell treatments {#s4-9}
----------------------------------------------

pTagBFP-C (Evrogen, Moscow, RU) was used to generate the expression constructs of Rab5 and EHD2 wt or I157Q. The cavin1-GFP construct was a kind gift from Prof. Robert G. Parton. Cav1-mCh HeLa cells were transfected with Lipofectamine 2000 (Thermo Fisher Scientific) using Opti-MEM I reduced serum medium (Thermo Fisher Scientific) for transient protein expression. For EHD2 and Cav1 depletion, Cav1-mCh HeLa cells were transfected with either stealth siRNA, specific against human EHD2 or human Cav1, or scrambled control (all from Thermo Fisher Scientific) using Lipofectamine 2000 and Opti-MEM according to manufacturer's instructions unless otherwise stated. Cells were transfected twice over a period of 72 h before the experiment. Protein levels were analyzed by SDS-PAGE and immunoblotting using rabbit anti-EHD2, RRID:[AB_2833022](https://scicrunch.org/resolver/AB_2833022) ([@bib36]) and rabbit anti-Cav1 antibodies, RRID:[AB_303405](https://scicrunch.org/resolver/AB_303405) (Abcam, Cambridge, UK). Mouse anti-clathrin heavy chain, RRID:[AB_397865](https://scicrunch.org/resolver/AB_397865) (clone 23, BD Transduction Laboratories, San Jose, CA, US) was used as loading control. Cells were treated with 2.5 μM myriocin in complete medium 24 h prior to harvesting. SMase was added to cells to generate a final concentration of 0.01 units in complete medium 2 h prior to harvesting or live cell imaging.

Analysis of caveolae dynamics {#s4-10}
-----------------------------

To track caveolae dynamics, induced Cav1-mCh HeLa cells were treated with fusogenic liposomes (7 nmol/ml) and 5 min TIRF movies were recorded with an acquisition time of 3 s. Imaris software was used for tracking analysis of Cav1-mCh positive structures (no distinction between single caveolae and Rosetta's are made), which were segmented as spots and structures with a diameter of 0.4 μm and with an intensity quality of 2% were selected ([Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}) as previously described ([@bib35]). The applied algorithm was based on Brownian motion with max distance travelled of 0.8 μm and a max gap size of 4. Experiments where cavin1-GFP or EHD2 (wt and mutant) was either transiently expressed or depleted were performed and analyzed the same way. Colocalization of cavin1-GFP or EHD2 (wt and mutant) to Cav1-mCh was quantified with Imaris software. Within a ROI, spots were created in one channel (e.g., red channel) and the second channel (e.g., blue channel) was masked. The masked spots show only colocalized red and blue spots and the percentage was correlated to the original channel. Analysis of the dynamic behavior of caveolae positive for or lacking EHD2-BFP was performed using double Flp-In EHD2-BFP Cav1-mCh HeLa cells. The tracking was done as described above and the data from the tracks of Cav1-mCh spots lacking EHD2-BFP were collected and removed from the data of Cav1-mCh spots positive for EHD2-BFP. Statistical analysis was performed on track duration(s) and track mean speed (μm/s) data and data areshown as fold change. All micrographs and acquired movies were prepared with Fiji, RRID:[SCR_002285](https://scicrunch.org/resolver/SCR_002285) ([@bib47]) and Adobe Photoshop CS6, RRID:[SCR_014199](https://scicrunch.org/resolver/SCR_014199).

Intracellular trafficking of lipids {#s4-11}
-----------------------------------

Induced Cav1-mCh HeLa cells were seeded on glass coverslips (CS-25R15) in a six-well plate at 3 × 10^5^ cells/well (37°C, 5% CO~2~). On the following day, the cells were incubated with fusogenic liposomes (7 nmol/ml) for 15 min or 3 h. Rab5-BFP ([@bib13]) was transiently expressed. To analyze the localization of lipids to lipid droplets (LDs), induced Cav1-mCh HeLa cells were treated with lipids for 15 min or 3 h, fixed and stained with HCS LipidTOX Deep Red Neutral Lipid Stain (1:200, Thermo Fisher Scientific). Confocal stacks were acquired on Zeiss Spinning Disk Confocal microscope. The colocalization of lipids to Rab5-positive structures or LD as well as localization of Cav1-mCh to Rab5-positive structures was analyzed as described above using a masking method in Imaris software. Micrographs were prepared with Fiji (RRID:[SCR_002285](https://scicrunch.org/resolver/SCR_002285)) ([@bib47]) and Adobe Photoshop CS6 (RRID:[SCR_014199](https://scicrunch.org/resolver/SCR_014199)).

Immunostaining {#s4-12}
--------------

Induced Cav1-mCh HeLa cells were seeded on precision coverslips (No. 1.5H, Paul Marienfeld GmbH and Co. KG, Lauda-Königshofen, DE) in 24-well plates at 50 × 10^3^ cells/well and incubated overnight (37°C, 5% CO~2~). Following incubation with fusogenic liposomes (7 nmol/ml) for 1 h, the cells were washed three times with phosphate-buffered saline (PBS, pH 7.4). Cells were fixed with 4% PFA in PBS (Electron Microscopy Sciences, Hatfield, PA, US) and subsequent permeabilization and blocking was carried out simultaneously using PBS containing 5% goat serum and 0.05% saponin. Cells were then immunostained with rabbit anti-EHD2 ([@bib36]) and rabbit anti-PTRF, RRID:[AB_88224](https://scicrunch.org/resolver/AB_88224) (Abcam) followed by goat anti-rabbit IgG secondary antibody coupled to Alexa Fluor 647, RRID:[AB_2535814](https://scicrunch.org/resolver/AB_2535814) (Thermo Fisher Scientific) as previously described ([@bib33]). Confocal images were acquired using the Zeiss Spinning Disk Confocal microscope (63X lens). Pearson colocalization coefficients were obtained using Imaris software applying the Coloc feature with automatic thresholding. All Pearson coefficients were derived from two independent experiments for the EHD2 stain. Analysis of the colocalization of cavin1 and Cav1-mCh was repeated once. Data from at least 30 images were analyzed with images containing two to three cells on average. For caveolae expression levels, induced (0.5 ng/ml Dox) and non-induced Cav1-mCh HeLa cells were seeded and fixed as described above. Cells were immunostained with rabbit anti-Caveolin1 (Abcam) followed by goat anti-rabbit IgG secondary antibody coupled to Alexa Fluor 488 (Thermo Fisher Scientific). Confocal images were acquired using the Zeiss Spinning Disk Confocal microscope (63X lens). Caveolae spots were counted using the Imaris software with the same preferences as described above. Micrographs were prepared using Fiji ([@bib47]) and Adobe Photoshop CS6.

FRAP experiments {#s4-13}
----------------

Induced Cav1-mCh HeLa cells were seeded on glass coverslips (CS-25R15) in a six-well plate at 3 × 10^5^ cells/well and incubated overnight (37°C, 5% CO~2~). Cells were treated with 7 nmol/ml of Bodipy-labeled liposomes for 10 min followed by two washes with live cell media before imaging using TIRF using a Zeiss Axio Observer.Z1 inverted microscope. Three reference images were recorded before a ROI was photobleached for 1000 ms using maximal laser intensity (488 nm or 561 nm). The fluorescent recovery images were taken every 3 s for 5 min. For the lipid incorporation experiment, a region within the PM with homogeneous fluorescence was chosen. FRAP of the EHD2 mutants was performed the same way. For the Bodipy-LacCer, Bodipy-Chol, and Bodipy-SM C~12~ accumulated in caveolae, FRAP was performed between 15 and 60 min after lipid addition and regions with structures positive for Cav1-mCh, EHD2-BFP, and Bodipy-lipid were selected and for the bulk PM a region lacking caveolae was selected. For FRAP experiments that quantified the recovery of Cav1-mCh, induced Cav1-mCh HeLa cells were untreated, depleted of EHD2 using siRNA, or incubated with Bodipy-LacCer liposomes. FRAP experiments were performed as described above using the Zeiss Spinning Disk Confocal microscope (63X lens). The signal recovery was monitored in focal plane close to the basal membrane. The intensities of the bleached regions were corrected for background signal and photobleaching of the cell. Data from at least 10 cells were collected per condition and mean FRAP recovery curves were plotted using Prism 5.0 (GraphPad, San Diego, CA, US; RRID:[SCR_002798](https://scicrunch.org/resolver/SCR_002798)).

Microinjection {#s4-14}
--------------

Mouse EHD2 cysteine mutant construct (L303C,C96S, C138S, C356S) was expressed as N-terminal His~6~-tag fusion proteins in *Escherichia coli* Rosetta (DE3) and purified ([@bib9]). Dithiothreitol was removed from the protein using PD-10 columns and the protein was labeled with Alexa Fluor 647 C2 Maleimide (Thermo Fisher Scientific) ([@bib21]). The protein was diluted to a concentration of 0.5 mg/ml in 150 mM NaCl, 20 mM HEPES pH 7.5, and 1 mM MgCl~2~. Cav1-mCh HeLa cells were transfected with siRNA and induced as described above. One day prior to the injection experiment, Cav1-mCh HeLa cells were seeded in MatTek dishes (35 mm dish, high tolerance 1.5, MatTek Corporation, Ashland, MA, US) with a cell density of 3 × 10^5^ cells/dish and induced with Dox. In the case of LacCer addition, the cells were treated with 7 nmol/ml of Bodipy-LacCer fusogenic liposomes for 10 min followed by two washes with live cell media before microinjection. Microinjection was performed with Injectman NI2 coupled to the programmable microinjector Femtojet (Eppendorf, Hamburg, DE). The protein was loaded in Femtotips II (Eppendorf) and injection was done with an injection pressure of 1.0 hPa, compensation pressure of 0.5 hPa, and injection time of 0.1 s. Live images were acquired on TIRF every 3 s for a total of 5 min using a Nikon Eclipse Ti-E inverted microscope with a 100X lens (Apochromat 1.49 Oil 0.13--0.20 DIC N2, Nikon) using NIS Elements (RRID:[SCR_014329](https://scicrunch.org/resolver/SCR_014329)). Z-stacks of injected cells were captured using a 60X lens (Apochromat 1.4o Oil DIC, Nikon). Tracking of Cav1-mCh and colocalization analysis was done with Imaris as previously described.

Correlative light electron microscopy {#s4-15}
-------------------------------------

Cav1-mCh cells transiently expressing EHD2-GFP alone or treated with Bodipy-LacCer, Bodipy-Chol, or Bodipy-SM C~12~ liposomes were fixed in 2% paraformaldehyde (PFA) and 0.2% glutaraldehyde (Taab Laboratory Equipment Ltd, Aldermaston, UK) in 0.1 M phosphate buffer (pH 7.4) for 1--2 h and then stored in 1% PFA at 4°C. For the grid preparation, the cells were scraped into the fixative solution and washed three times with PBS (pH 7.4) and once with PBS containing 0.1% glycine (pH 7.4, Merck Millipore, Burlington, US). The cell pellet was embedded in 12% gelatin (Dr. Oetker, food grade) in 0.1 M phosphate buffer (pH 7.4). Blocks of around 1 mm^2^ were cut and cryo-protected by overnight infiltration in 2.3 M sucrose (VWR) in 0.1 M phosphate buffer. Next, the blocks were plunge frozen in liquid nitrogen. The sample block was sectioned at −120°C to obtain 80 nm sections. These were mounted in a drop of in 0.1 M phosphate buffer containing 1:1 of 2% methyl cellulose (Sigma-Aldrich) and 2.3 M sucrose on TEM grids with a carbon-coated Formvar film (Taab Laboratory Equipment Ltd). The grids were incubated with PBS (pH 7.4) at 37°C for 20 min and stained with DAPI (4\',6-Diamidino-2-Phenylindole, Dilactate, 1:1000 in PBS, pH 7.4, Thermo Fisher Scientific) before imaging on a Nikon Eclipse Ti-E inverted microscope with a 100X lens (Apochromat 1.49 Oil 0.13--0.20 DIC N2, Nikon). Low magnification images were taken at 20X for orientation on the grid and to aid the overlay of fluorescent microscopy images and the higher resolution images of TEM. Contrasting for TEM was done by embedding the grids in 1.8% methyl cellulose and 0.4% uranyl acetate (Polysciences, Inc, Hirschberg an der Bergstrasse, DE) solution prepared in water (pH 4) for 10 min in the dark. TEM was performed with a Talos 120C transmission electron microscope (FEI, Eindhoven, NL) operating at 120kV. Micrographs were acquired with a Ceta 16M CCD camera (FEI) using Maps 3.3 (FEI, Hillsboro, OR, US). The fluorescent images were overlaid atop TEM images of the same cells collected from the ultrathin section using Adobe Photoshop CS6.

Electron microscopy {#s4-16}
-------------------

3T3-L1 cells were seeded on MatTek dishes (35 mm dish, high tolerance 1.5) and differentiated to adipocytes as described above. 3T3-L1 adipocytes were untreated or incubated with Bodipy-Chol liposomes for 45 min, washed with PBS, and fixed as follows. All chemical fixation steps were performed using a microwave (Biowave, TED PELLA, inc) unless stated and solutions were prepared and rinses were performed in 0.1M cacodylate buffer (Sigma-Aldrich) or water. Fixation of the cells was performed in 0.05% malachite green oxalate (Sigma-Aldrich) and 2.5% gluteraldehyde (Taab Laboratory Equipment Ltd, Aldermaston, UK) in cacodylate buffer. The samples were rinsed four times with cacodylate buffer and post-fixed with 0.8% K~3~Fe(CN)~6~ (Sigma-Aldrich) and 1% OsO~4~ (Sigma-Aldrich) in cacodylate buffer and rinsed four times with cacodylate buffer. The samples were then stained with 1% aqueous tannic acid (Sigma-Aldrich). Following two rinses in cacodylate buffer and water, samples were stained with 1% aqueous uranyl acetate (Polysciences, Inc, Hirschberg an der Bergstrasse, DE). After four washes with water, samples were dehydrated in gradients of ethanol (25%, 50%, 75%, 90%, 95%, 100% and 100%) (VWR). The samples were infiltrated with graded series of hard grade spurr resin (Taab Laboratory Equipment Ltd, Aldermaston, UK) in ethanol (1:3, 1:1 and 3:1) and then left in 100% resin for 1 h at room temperature. The samples were later polymerized overnight at 60°, sectioned and imaged with a Talos 120C transmission electron microscope (FEI, Eindhoven, NL) operating at 120kV. To obtain quantitative data, segmentation of caveolae for measurement of bulb width and measurement of neck diameter for surface-connected caveolae was performed with 'icy' ([@bib10]). To extract bulb width and surface area, the 'active cells' plug-in was used with three points to make an elliptical contour that fitted individual caveolae. The neck diameter was obtained by drawing a ROI across the neck of surface-connected caveolae. The analysis was performed blinded and with randomized sections.

Statistical analysis {#s4-17}
--------------------

Statistical analysis was carried out by two-tailed unpaired Student *t*-test for comparison with control samples using GraphPad Prism 5.0 software. All experiments were performed at least twice with data representing mean ± SEM unless otherwise stated.
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In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.

**Acceptance summary:**

Caveolae are dynamic structures at the plasma membrane (PM) that can undergo scission and endocytosis. It has been a longstanding challenge to study the effect of PM lipids on caveolar structures. In this study, Hubert et al. present a solution through elegant use of fusogenic liposomes, which allows for acute perturbation of the PM lipid composition. The authors show that scission of caveolae from the cell surface is driven by cholesterol and glycosphingolipid accumulation in these structures.

**Decision letter after peer review:**

Thank you for submitting your article \"Lipid accumulation promotes scission of caveolae\" for consideration by *eLife*. Your article has been reviewed Suzanne Pfeffer as the Senior Editor, a Reviewing Editor, and three reviewers. The following individuals involved in review of your submission have agreed to reveal their identity: Shiro Suetsugu (Reviewer \#1); Ivan R Nabi (Reviewer \#2).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

Caveolae are dynamic structures at the plasma membrane (PM) than can undergo scission and endocytosis. It has been technically challenging to study in detail the effect of PM lipids on caveolar structures. Here, Hubert et al. present the original use of fusogenic liposomes to perturb the lipid composition of PMs and monitor changes in caveolae structures. All three reviewers were supportive and agreed that this work was an interesting contribution to this field. However, as listed below, they did raise several concerns that will require additional experiments and/or explanations in the text.

Essential revisions:

1\) In the Abstract, the authors say that \"cholesterol and glycosphingolipids specifically accumulate in caveolae, which decreases their neck diameter and drives their scission from the cell surface.\" The data supporting the scission seems to be the reduced track duration. However, the end of tracking does not necessarily mean the scission from cell surface and could be explained by disassembly into a flat membrane. Either rephrase or provide data that distinguishes between these possibilities.

2\) In the Abstract, the authors say that \"lipid-induced scission was counteracted by the ATPase EHD2. We propose that lipid accumulation in caveolae generates an intrinsically unstable domain prone to scission if not balanced by the restraining force of EHD2 at the neck.\" This requires further clarification. How does the EHD2 counteracted with the imbalance of lipid? The importance of the ATPase activity of EHD2 might also be better analyzed with the ATPase deficient mutant in addition to I157Q mutant.

3\) The addition of lipids via fusogenic liposomes is the fundamental basis of the study and needs to be thoroughly characterized. Why is the lipid distribution by TIRF in Figure 1B homogenous but not in Figure 1F? How does this non-homogeneous distribution overlap with Cav1 spots? Does homogeneity of insertion vary for different lipids? Are lipid expression levels the same for different cells in the same population?

4\) Caveolae dynamics are inferred from TIRF imaging of Cav1-mCherry. A key aspect of this approach is how caveolae are defined from Cav1 fluorescent spots, which needs to be more clearly defined in the text. The text states a set threshold was applied to define caveolae Cav1 spots but the Materials and methods section indicates that spots larger than 0.4 µm diameter were selected. Why was this size limit selected (caveolae are \<100 nm and diffraction limit is \~200-250nm)? Was no intensity threshold applied? What is the intensity distribution of large vs small spots? To what extent is Cav1-mCherry expression similar between cells and how robust is the application of \"caveolae\" selection criteria between cells? From the movies, the number of bright large spots clearly varies between cells. If these are the ones the authors are considering to be caveolae then how to explain that some cells have so few caveolae? And how to exclude that these structures are rosettes, associated with EHD2 expression? How can the authors exclude the possibility that the changes in mobility they are seeing relate not to caveolae scission but to rosette fragmentation? Please include figures and videos showing the spots selected for study, along with superimposed tracks. A clear discussion of criteria used to assign Cav1 spots as individual caveolae should be included.

5\) The fusogenic liposomes allow for the incorporation of lipid species specifically enriched in caveolae such as cholesterol, sphingomyelin, ceramides and glycosphingolipids. To prove that the regulation of caveolae stability is specific for caveolar lipids, it would be nice if the authors could show that caveolae dynamics are not perturbed after the addition of other phospholipids, found outside caveolae, such as PC, PA, PG. In parallel, the tracking experiments only focus on Cav1 dynamics upon liposome fusion (Figure 2 and Figure 3E-H). But it is not clear whether other non-caveolar PM protein (clathrin HC for instance) dynamics would be changed after addition of the selected lipids? These data would strongly support the specificity of the described phenomenon.

6\) Figure 2A presents a schematic of how track durations are interpreted to reflect caveolae dynamics. The basis for these classifications is not clearly presented nor is it clear why they are required. Indeed, why even introduce the surface adjacent class which according to the quantification in Figure 2B is very much a minority of the tracks detected. The data in Figure 2B clearly shows that EDH2 siRNA reduces the number of tracks with slow track speed for essentially all track durations, clearly reflecting the increased scission of caveolae upon EDH2 knockdown. In light of authors concerns with respect to reliability of track duration, why not just use the simple classification of track speed used in 2B to analyze the effects of lipids on caveolae dynamics.

7\) The effect of SM-C12 addition to EDH2 overexpressing cells is interesting. What is the effect of sphingomyelinase treatment on EDH2 OE cells?

8\) Please include the data for control siRNA in Figure 3C and Figure 3F.

9\) Some of the lipids exhibit less efficient incorporation (SM C5 and C12 and to a lesser extent Cer). Since all experiments are done with the same amount of liposomes, this could explain why tracking parameters (Figure 3D, F) are not different from control condition. Will adding 3 times more SM C5 perturb caveolae dynamics?

10\) Is the lipid-induced caveolae scission purely driven by lipids through membrane curvature perturbations or is it mediated by membrane pinching proteins? The authors should test the involvement of dynamin2, which is known to associate with the neck of caveolae and favor their internalization. Less EHD2 is colocalized with Cav1-mCherry 1h after the fusion of liposomes containing GM1, LacCer or Chol but is Dynamin2 found more often with Cav1 positive structures under these conditions?

11\) The diffusion of lipids on caveolae is an important part of this manuscript. Please include this point in the Abstract. Please highlight a comparison of FRAP at caveolae to that of the bulk PM is necessary for discussing the diffusion of lipids in caveolae and in bulk PM. In Figure 4D, the FRAP curves are of ROIs, but these ROIs are not specified.

12\) In Figure 4C, it is not clear what the bleach zone is and in Figure 4D why is this analysis not extended to other lipids? Similar for the EM studies in Figure 5, why are these not performed for other lipids, in particular SM-C12?

13\) Please clarify the difference between the upper and lower panels in Figure 5B and 5C. Also, clarify why is meant by different appearance between the upper and lower panels. The shape measurements were done only for the cholesterol-supplemented cells, this analysis should also be carried out for the LacCer-supplemented cells.

14\) In Figure 5, if caveolae scission was enhanced, then some of them would go to endosomes. Is this the case? Some control experiments using, for instance, Bodipy-PE would be informative.

15\) The results of Figure 6 show no obvious effect of Cav1 depletion on endosomal localization of Bodipy-lipids. So, after scission what is the fate of lipid filled internalized caveolae? Do they stay in the vicinity of PM and fuse back? What is the amount/fraction of lipids (LacCer) found in Rab5 positive structures after 15 minutes and 3 hours? Also, the possibility of caveolae flattening induced by lipid loading of the PM should be assayed. Figure 3B shows colocalization of Cav1-mCh with endogenous Cavin1 in maximum z-projection of confocal images. The authors should also monitor Cav1-Cavin colocalization by TIRF and compare the number of Cav1 positive structure/dot colocalizing with Cavin1, before and after addition of fusogenic liposomes, and see if this condition triggers caveolae disappearance/disassembly (not internalization).

16\) Experiments where lipid composition is changed in the opposite direction would enhance the arguments of this paper. It would be useful to compare the effects of cholesterol depletion, by methyl-β-cyclodextrin treatment for example.

10.7554/eLife.55038.sa2

Author response

> Essential revisions:
>
> 1\) In the Abstract, the authors say that \"cholesterol and glycosphingolipids specifically accumulate in caveolae, which decreases their neck diameter and drives their scission from the cell surface.\" The data supporting the scission seems to be the reduced track duration. However, the end of tracking does not necessarily mean the scission from cell surface and could be explained by disassembly into a flat membrane. Either rephrase or provide data that distinguishes between these possibilities.

We agree with the reviewer that this is an essential conclusion of the manuscript and this is why we have performed so many experiments to test this hypothesis. We have now added more experiments and further improved the schematic Figure 2A and clarified the text regarding how the different states of caveolae and how they would be reflected in our data. We have also improved the description of how caveolae were assigned and tracked (see also point 4). The data that support our conclusion on scission is presented in Figure 2 and Figure 3 together with supplemental figures and text. In brief, we have analyzed the number of tracks before and after treatment and saw no significant difference (Figure 2---figure supplement 2C), which would be expected if caveolae were disassembled. We have now also clarified the text regarding this. We have analyzed the duration and speed of caveolae and find that the duration is decreased while speed is increased following incorporation of glycosphingolipids and Chol. This is consistent with scission of caveolae and we also control for this by the analysis of EHD2 KO cells in which scission of caveolae is increased (Moren et al., 2012, Stoeber et al., 2012, Matthaeus et al., 2020). The increased speed would however not be consistent with disassembled caveolae.

We go on to test our hypothesis in Figure 3. In Figure 3A, we analyze if the treatment results in altered colocalization with EHD2 (would indicate surface release) and cavin1 (would indicate disassembly). We find that colocalization with EHD2, but not cavin1 is affected by glycosphingolipids and Chol supporting scission. We have now complemented the experiments with new data as suggested under point 15. To further assess this, we have now performed new experiments where we have analyzed the colocalization of cavin1 and Cav1 in live cells using TIRF before and after treatment. These data show that the colocalization between cavin1 and Cav1 is not altered following lipid incorporation again supporting that the detected effect is due to scission (See also response to comment 15).

Furthermore, as stated in the manuscript, caveolae scission would result in more mobile caveolae inside cells as previously shown. In Figure 3C we show that indeed lipid addition induces more mobile caveolae as does EHD2 depletion. Disassembly or flattening of caveolae would not result in this. We can also suppress the lipid-induced effect by overexpressing EHD2, which again indicates that the lipid-effect induces scission. To control for that the EHD2 expression is not due to secondary effect due to long term expression of EHD2, we microinject EHD2 and observe the same effect. In addition, in Figure 3E, if lipid addition and EHD2 depletion both induce caveolae scission then there should not be an additive effect of these treatments and indeed this is what we detect in Figure 3E.

In summary, given these experiments and results, we conclude that the increased dynamics of caveolae following increased levels of glycosphingolipids and Chol are most likely via scission of caveolae and therefore we have kept this statement in the Abstract.

> 2\) In the Abstract, the authors say that \"lipid-induced scission was counteracted by the ATPase EHD2. We propose that lipid accumulation in caveolae generates an intrinsically unstable domain prone to scission if not balanced by the restraining force of EHD2 at the neck.\" This requires further clarification. How does the EHD2 counteracted with the imbalance of lipid? The importance of the ATPase activity of EHD2 might also be better analyzed with the ATPase deficient mutant in addition to I157Q mutant.

In the revised manuscript, we have now more clearly presented the previously described mechanistic cycle for how EHD2 assemble and stabilize the caveolae neck to prevent scission and restrain caveolae to the cell surface via assembly into ring-like oligomeres (Daumke et al., 2007, Hoernke et al., 2017). Here, we go on to show that the accumulation of specific lipids in caveolae promote scission and destabilize their surface association but that this can be restrained by EHD2 (overexpression or microinjection). Therefore, we propose that the components (both proteins and lipids) building up the caveolae bulb creates a highly curved intrinsically unstable domain prone to scission, but that EHD2 provides a restraining force at the caveolae neck preventing scission.

Regarding the role of ATP-hydrolysis, we have previously generated and characterized different mutants of EHD2 and their effects on binding and hydrolysis of ATP as well as caveolae (Daumke et al., 2007, Moren et al., 2012). The ATPase impaired mutant T94A cause overassembly of EHD2 and membrane tubulation (since the regulatory ATPase activity is impaired). This mutant tubulates the caveolae neck, and it is therefore difficult to draw direct conclusions for how ATP-hydrolysis in itself influence the ability of EHD2 to stabilize lipid-induced scission of caveolae based on this mutant. In this work, we aimed to use the I157Q mutant, where ATP-hydrolysis is uncoupled to ATP-hydrolysis, which therefore form oligomeres with a slow dissociation time but without overassembly. This allows us to study if oligomerization of EHD2 at the caveolae neck is sufficient to prevent lipid induce scission or weather the stabilization requires constant adaptation of EHD2 assembly/dissassembly via rounds of ATP-hydrolysis. We have made this clearer in the text.

> 3\) The addition of lipids via fusogenic liposomes is the fundamental basis of the study and needs to be thoroughly characterized. Why is the lipid distribution by TIRF in Figure 1B homogenous but not in Figure 1F? How does this non-homogeneous distribution overlap with Cav1 spots? Does homogeneity of insertion vary for different lipids? Are lipid expression levels the same for different cells in the same population?

We agree that this is an important part of the study, and we have now added text in the Results section that addresses these questions and refers to our extensive characterization throughout the manuscript (see Figure 1B, 1F, Figure 2C, Figure 4A-D, Figure 2---figure supplement 2A, Figure 2---video 2, Figure 2---video 3, Figure 2---video 4, Figure 3---figure supplement 1A, Figure 4---figure supplement 2A-D) to better characterize the lipid fusion and distribution of the lipids in the beginning of the Results section.

Lipid incorporation was similar for all cells in the population as also observed in Figure 1B, Figure 2C and Figure 2---figure supplement 2A. The even distribution of lipids in the PM was observed for all lipid species (see data throughout manuscript). Occasionally, however, bright stable spots and some enrichment of lipids in cellular protrusions were observed independent of lipid species as was shown in Figure 1B. These structures did not colocalize with Cav-1. We have now changed Figure 1F in order not to cause confusion.

> 4\) Caveolae dynamics are inferred from TIRF imaging of Cav1-mCherry. A key aspect of this approach is how caveolae are defined from Cav1 fluorescent spots, which needs to be more clearly defined in the text.

Thank you for bringing it to our attention that the spot analysis could be explained in more detail. This has now been clarified in the Materials and method section. We have also added a detailed figure that outlines the method in Imaris software for illustration of spot selection (Figure 2---figure supplement 3).

> The text states a set threshold was applied to define caveolae Cav1 spots but the Materials and methods section indicates that spots larger than 0.4 µm diameter were selected. Why was this size limit selected (caveolae are \<100 nm and diffraction limit is \~200-250nm)?

Several caveolae-mCh spots were empirically measured from TIRF images and spots with a diameter of 0.4 µm rendered the best spot analysis as compared to the movies (Figure 2---figure supplement 3). This has been clarified in the Materials and Method section and an according literature reference added.

> Was no intensity threshold applied? What is the intensity distribution of large vs small spots?

Yes, an intensity threshold was applied that was based on intensity quality of the spots and we have added all relevant details to the Materials and method section. A detailed figure that outlines the method in Imaris software has been added for illustration of spot selection (Figure 2---figure supplement3).

> To what extent is Cav1-mCherry expression similar between cells and how robust is the application of \"caveolae\" selection criteria between cells? From the movies, the number of bright large spots clearly varies between cells. If these are the ones the authors are considering to be caveolae then how to explain that some cells have so few caveolae?

We have now added a figure (Figure 1---figure supplement 4), which shows that the Dox induced Cav1-mCh expression is similar to the endogenous caveolae levels as compared to non-induced cells that had been fixed and stained against Caveolin1. Caveolae from fixed and live cells were counted using the Imaris software and similar numbers of caveolae was identified showing that the application is reliable.

> And how to exclude that these structures are rosettes, associated with EHD2 expression? How can the authors exclude the possibility that the changes in mobility they are seeing relate not to caveolae scission but to rosette fragmentation?

We do see some spots that are larger and of greater intensity than others which could be rosettas or just caveolae close to each other. In the CLEM analysis of caveolae in Hela cells we do only rarely detect rosettas. However, using TIRF we don't have the resolution to determine this. Occasionally, we have observed that one spot can break up into two spots although this is rare. We do not observe any increase in the number of caveolae spots following treatments which would be the case if many clusters or rosettas are fragmented. Furthermore, the observed increase in speed of caveolae following incorporation of Chol and sphingolipids is too fast to be explained by increased lateral diffusion of individual caveolae. Fragmentation of rosettas in terms of scission would be indistinguishable from scission of individual caveolae.

> Please include figures and videos showing the spots selected for study, along with superimposed tracks. A clear discussion of criteria used to assign Cav1 spots as individual caveolae should be included.

A detailed figure that outlines the method in Imaris software has been added for illustration of spot selection (Figure 2---figure supplement 3).

> 5\) The fusogenic liposomes allow for the incorporation of lipid species specifically enriched in caveolae such as cholesterol, sphingomyelin, ceramides and glycosphingolipids. To prove that the regulation of caveolae stability is specific for caveolar lipids, it would be nice if the authors could show that caveolae dynamics are not perturbed after the addition of other phospholipids, found outside caveolae, such as PC, PA, PG. In parallel, the tracking experiments only focus on Cav1 dynamics upon liposome fusion (Figure 2 and Figure 3E-H). But it is not clear whether other non-caveolar PM protein (clathrin HC for instance) dynamics would be changed after addition of the selected lipids? These data would strongly support the specificity of the described phenomenon.

We have now clarified in the text that we do not only analyze lipids known to be enriched in caveolae and that the precise lipidomics of caveolae is not known. The lipids in our study are carefully selected, where we use a glycerophospholipid PE (not caveolae enriched), glycosphingolipids LacCer and GM1 (proposed to be enriched), Ceramide (not enriched, but used to compare to glycosylated LacCer and GM1), sphingomyelin (proposed to be enriched) and Chol (proposed to be enriched). We agree that there are more lipids that could be interesting to study but that this would be out of the scope for this study.

We do not intend to claim that an altered lipid composition will specifically affect only caveolae dynamics. This could also affect for example clathrin coated pits (CCP), but, in order to be useful such studies would have to be put into context of CCP-formation and dynamics, which would require a complete design dedicated to such system. Such measurement would require setting up and controlling this system and performing all relevant controls to validate potential effects as we have now done for the caveolae system in this manuscript. Therefore, although interesting, we believe that this would need to be addressed in further studies.

> 6\) Figure 2A presents a schematic of how track durations are interpreted to reflect caveolae dynamics. The basis for these classifications is not clearly presented nor is it clear why they are required. Indeed, why even introduce the surface adjacent class which according to the quantification in Figure 2B is very much a minority of the tracks detected. The data in Figure 2B clearly shows that EDH2 siRNA reduces the number of tracks with slow track speed for essentially all track durations, clearly reflecting the increased scission of caveolae upon EDH2 knockdown. In light of authors concerns with respect to reliability of track duration, why not just use the simple classification of track speed used in 2B to analyze the effects of lipids on caveolae dynamics.

We agree that the classification was not clearly described, and we thank the reviewer for pointing this out. We have now reworked the schematic figure (Figure 2A) and the section of the text describing the classification. We also agree that the track speed should be used to analyze the effects on caveolae dynamics along with duration and have now clarified this in the text.

> 7\) The effect of SM-C12 addition to EDH2 overexpressing cells is interesting. What is the effect of sphingomyelinase treatment on EDH2 OE cells?

To address this, we have performed new experiments analyzing the effects of SMase on caveolae dynamics when EHD2 is overexpressed. The data is presented in the text and in Figure 3F and shows that EHD2 can partly restrain the decreased duration and increased speed of caveolae induced by reduced SM-levels.

> 8\) Please include the data for control siRNA in Figure 3C and Figure 3F.

We have added the data for control siRNA in Figure 3C. We assume that the reviewer is referring to Figure 3E instead of F, and we would like to point out that the data for control siRNA is presented in Figure 3---figure supplement 2B.

> 9\) Some of the lipids exhibit less efficient incorporation (SM C5 and C12 and to a lesser extent Cer). Since all experiments are done with the same amount of liposomes, this could explain why tracking parameters (Figure 3D, F) are not different from control condition. Will adding 3 times more SM C5 perturb caveolae dynamics?

We have now performed experiments where 3 times more liposomes containing SMC5 has been added to cells. The incorporation of this lipid was thereby increased (Figure 2D), but yet no effect on the dynamics of caveolae was detected (Figure 2---figure supplement 2D).

> 10\) Is the lipid-induced caveolae scission purely driven by lipids through membrane curvature perturbations or is it mediated by membrane pinching proteins? The authors should test the involvement of dynamin2, which is known to associate with the neck of caveolae and favor their internalization. Less EHD2 is colocalized with Cav1-mCherry 1h after the fusion of liposomes containing GM1, LacCer or Chol but is Dynamin2 found more often with Cav1 positive structures under these conditions?

We completely agree that this is a very interesting question. However, it will require very far-reaching mechanistic studies to elucidate this in order not to jump the conclusions. We are performing an extensive study of the role of dynamin2 in caveolae scission in collaboration with several research groups. This work is still in progress, but it is clear that our data are not fully consistent with current literature on the role of dynamin2, which is very interesting. We aim to put together a comprehensive study of dynamin2 and caveolae and therefore the addition of individual data regarding dynamin2 in the current manuscript would risk to cause distort the overall conclusions on the role of dynamin2.

> 11\) The diffusion of lipids on caveolae is an important part of this manuscript. Please include this point in the Abstract. Please highlight a comparison of FRAP at caveolae to that of the bulk PM is necessary for discussing the diffusion of lipids in caveolae and in bulk PM. In Figure 4D, the FRAP curves are of ROIs, but these ROIs are not specified.

Thanks, these are very good suggestions, and we have now specified the ROIs where recovery curves are measured and included the comparison of the recovery in caveolae and in the surrounding PM (Figure 4E and Figure 4---figure supplement 3). We agree that this is an important part of the manuscript and have added lipid diffusion and sequestering to the Abstract.

> 12\) In Figure 4C, it is not clear what the bleach zone is and in Figure 4D why is this analysis not extended to other lipids? Similar for the EM studies in Figure 5, why are these not performed for other lipids, in particular SM-C12?

Thanks for pointing this out. We have now made a clearer presentation of the bleached zone and the ROIs where the recovery is analyzed. We have now also extended the analysis to include SM C~12~, which is also heavily enriched in caveolae in EHD2 overexpressing cells (Figure 4---figure supplement 3). See also response to point 11.

> 13\) Please clarify the difference between the upper and lower panels in Figure 5B and 5C. Also, clarify why is meant by different appearance between the upper and lower panels. The shape measurements were done only for the cholesterol-supplemented cells, this analysis should also be carried out for the LacCer-supplemented cells.

We apologize for not clearly describing the difference between upper and lower panels. This has now been added to the figure legend. We have also further explained how we use these data to quantify either the caveolae neck or the caveolae surface area.

The adipocyte cells were used as a system, where we can address the effect of Chol in a quantitative way since these cells are physiologically important for Chol homeostasis, the caveolea are enriched in Chol (Örtegren et.al., 2004), and these cells have numerous caveolae at the cell surface. Adipocyte cells do not and contain detectable levels of LacCer (Örtegren et.al., 2004). Therefore, we have not included analysis of LacCer incorporation since interpretation of such data, alongside Chol data, would be difficult given that we in that case would introduce a lipid not normally present in these cells. We have now clarified this in the text.

> 14\) In Figure 5, if caveolae scission was enhanced, then some of them would go to endosomes. Is this the case? Some control experiments using, for instance, Bodipy-PE would be informative.

In the CLEM analysis of HeLa cells, we did observe occasional internal red spots (Cav1-mCherry) where caveolae-like structures were fused to what appeared like endosomes. However, these were quite rare, preventing quantitative statements, and without further labelling the endosomal-like compartment could not be verified. We have therefore not included this in the manuscript. We have quantified the amount of caveolae that colocalize with Rab5 before and after lipid-treatment and we do not detect a significant change (Figure 6C). As mentioned in the text and in the response to comment 15, most of the scissioned caveolae appear to remain as surface adjacent caveolae following lipid-induced scission.

> 15\) The results of Figure 6 show no obvious effect of Cav1 depletion on endosomal localization of Bodipy-lipids. So, after scission what is the fate of lipid filled internalized caveolae? Do they stay in the vicinity of PM and fuse back? What is the amount/fraction of lipids (LacCer) found in Rab5 positive structures after 15 minutes and 3 hours? Also, the possibility of caveolae flattening induced by lipid loading of the PM should be assayed. Figure 3B shows colocalization of Cav1-mCh with endogenous Cavin1 in maximum z-projection of confocal images. The authors should also monitor Cav1-Cavin colocalization by TIRF and compare the number of Cav1 positive structure/dot colocalizing with Cavin1, before and after addition of fusogenic liposomes, and see if this condition triggers caveolae disappearance/disassembly (not internalization).

We do not see an altered number of spots in cells where caveolae are dynamic due to lipid addition, which suggest that they fission off and stay in vicinity or refuse. We have now clarified this in the text. As suggested, we have now also added a quantification of the amount of caveolae that colocalize to Rab5-positive structures before and after lipid-treatment. The percentages are quite low and we do detect a significant change following lipid treatment.

Thanks for the nice suggestion to analyze effects on caveolae disassembly/flattening by monitoring colocalization of Cav1 and cavin1 by TIRF. We have now performed these experiments before and after lipid treatments and the data is presented in Figure 3---figure supplement 1. We find that there is no significant difference in the amount of colocalization following incorporation of any of the lipids.

> 16\) Experiments where lipid composition is changed in the opposite direction would enhance the arguments of this paper. It would be useful to compare the effects of cholesterol depletion, by methyl-β-cyclodextrin treatment for example.

As mentioned in the manuscript, acute, but controlled decrease of the levels of specific lipids is technically challenging. We have been able to use SMase-treatmentto reduce the levels of SM (Figure 2G). We have also performed many experiments to optimize the use of MBCD (time and concentrations) to reduce the levels of Chol as suggested. However, treatment with MBCD results in an immediate and drastic shrinkage of the cells, whereby the tracking is obscured and impossible to quantify. Therefore, we are not confident to use this methodology to lower Chol levels and measure effects on caveolae dynamics.

[^1]: Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden.
